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Acute Myocardial Infarction (AMI) is the leading cause of worldwide death and 
disability, and approximately 720,000 Americans will experience an AMI in 2018. Studies 
have shown that rapid hypothermia therapy (< 35°C) before reperfusion in patients with 
AMI can reduce infarct size by 37%. Localized therapeutic hypothermia has proven the 
potential to cool heart tissue rapidly following AMI, 3°C in 5 minutes. Using Materialise 
Mimics digital imaging software and the finite volume method we analyzed temperature 
distributions in six patient-specific left main coronary artery (LMCA) models. A mock 
circulatory loop was used to determine the exiting temperatures of a standard 7 Fr catheter 
to feed into our model with flow rates ranging from 29.2 ml/min to 68.85 ml/min. Our work 
showed that therapeutic hypothermia (TH) temperatures were evident at the outlets of three 
out of all six heart models, which varied in each left anterior descending (LAD) and left 
circumflex (LCX) artery depending on flowrate. Results of this study indicate that 
biovariability in patient-specific vascular structures significantly impacts therapeutic 
hypothermia (TH) treatment methods. These results indicate that further research is needed 
to examine more accurate physiological effects, such as pulsatile flow and vessel wall 
thickness. Future models will be used to provide insight to guide more efficient TH device 
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Basic Physiology of the Human Heart 
The human heart is an organ made of muscle that is responsible for pumping 
blood to the rest of the body and to itself via the aorta [1][2]. The heart consists of two 
atria and two ventricle chambers (Fig. 1.1) where de-oxygenated blood enters the right 





Figure 1.1. Basic cardiac circulation of the human heart. The right side of the heart 
supplies blood to pulmonary circulation, while the left side of the heart supplies blood to 




The right atrium contracts and blood is pumped into the right ventricle. When the 
left ventricle contracts, deoxygenated blood is pumped to the lungs through the 
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pulmonary artery. In the lungs, blood releases carbon dioxide and loads up with oxygen. 
Oxygenated blood flows back into the left atrium, is pumped into the left ventricle, and 
then expelled into the aorta to sustain circulation.  
The circulatory system consists of the heart, blood, and blood vessels, and 
circulates an average of 5 liters of blood throughout the human body [2]. Diastolic blood 
flow refers to the relaxation of the atrial and ventricle chambers. Systolic blood flow 
refers to the contraction of the atria and ventricle chambers. These contractions are 
initiated by action potentials from electrical excitatory impulses, however, the 
electrophysiology of the heart is beyond the scope of this work.  
 Vascular networks. After blood is pumped into the aorta, it enters the left and 
right coronary arteries to provide oxygen and nutrients to the myocardium (heart muscle) 
[2]. The left main coronary artery (LMCA), which originates from the proximal aortic 
arch, supplies blood to the left myocardium and bifurcates into the left anterior 
descending artery (LAD) and the left circumflex artery (LCX) [4]. The LAD supplies 
blood to the front of the heart, while the LCX circles the left myocardium and supplies 
blood to the back of the heart. The oblique LAD and LCX networks bifurcate into many 






Figure 1.2. Image of the LMCA bifurcating into the LAD and LCX arteries that each 
branch into daughter vessels producing patient-specific artery networks. Each person has 
a unique coronary vascular network with arteries varying in length, diameter, and 





For the LAD, these branches consist of the 1st septal perforator, 1st and 2nd diagonal, and 
the proximal, mid, and distal branches [5]. For the LCX, these branches consist of the 
atrial, obtuse marginal, and the posterior lateral branches. For this work, extensive 
research was performed to assess and determine appropriate LMCA geometries [6][7][8], 
native coronary flow rates [9]–[12], and catheter infusate flow rates for intracoronary 
procedures [13][14]. 
 Coronary flow rates. Coronary flow rates have been measured in clinical settings 
using intracoronary doppler and ultrasound [11], phase contrast MRI video measurements 
[12], intracoronary frequency domain optical coherence tomography [15], and methods 
using doppler wires [16]. Using these methods, coronary flow rates ranged between 29.7 
ml/min and 107 ml/min in the LAD and 28.4 ml/min and 112 ml/min in the LCX 
[9][10][11][12]. Typical blood flow rates in the cardiac cycle (Fig 1.3) entering the left 
coronary artery network are pulsatile in nature and consists of the systole ejection phase 




Figure 1.3. The cardiac cycle for blood flow entering the left coronary artery [17]. The 
typical cardiac cycle is pulsatile in nature and consists of the systole ejection phase (SEP) 
and the diastole phase (DP), which represents the time between 0.3s to 0.5s and 0.5s to 




 Variations between patients. Coronary artery geometry variations between 
patients affect nearly 5.6% of Americans, and include varying bifurcation patterns, vessel 
lengths and diameters, and dominant/co-dominant LAD and LCX networks [18]. 
Branching patterns in LMCA networks between patients include high variations of 
bifurcations and trifurcations, and if misdiagnosed, could cause difficulties in 
catheterization surgeries [19]. 
Coronary artery anomalies are defects in the geometry of the coronary arteries and 
are linked to an abnormal size or varying origin location from the aortic arch. These 
coronary artery anomalies between patients vary between 0.2% to 8.4% [20], and have 
been associated with congenital heart disease and approximately 15% of young athletes 
that experience sudden death [20][21]. Determining geometry patterns and variations in 
the coronary arteries is important for physicians to competently treat and diagnose 
































Acute Myocardial Infarction (AMI) 
With the geometry and blood flow described, this research focuses on a common 
problem: acute myocardial infarction. Coagulation of inflammatory cells and calcium 
deposits may form on the inner walls of the coronary arteries, known as atherosclerotic 
plaque [22]. This plaque could rupture and form a clot (thrombus) to reduce blood flow 
or could form a complete blockage in the coronary arteries. This phenomenon can lead to 
insufficient nutrients and oxygen in the myocardium and is known as myocardial 
ischemia. If left untreated, the ischemia region can cause irreversible damage to the 
myocardium. This condition is known as acute myocardial infarction (AMI) [23]. 
Acute Myocardial Infarction (AMI) occurs when metabolically insufficient blood 
flows to the myocardium, resulting in cell death (necrosis) [23][24]. AMI is a primary 
cause of worldwide death and disability [23][25]. In contrast, AMI incidences have 
significantly declined over the past decade, however, it is estimated that 720,000 
Americans will experience a new AMI and 335,000 will have a recurrent event in 2018 
[26]. 
Permanent damage to the myocardium can result from AMI. While unresponsive 
to contractile function, fibrous scar tissue (infarct area) distal to a blocked artery 
(occlusion site) can form (Fig. 1.4) and cause impairment to left ventricular (LV) 







Figure 1.4. Schematic of left anterior descending artery occluded with plaque 
build-up. Purple area distal to occluded artery represents myocardial area at risk 
of infarction [27]. Therapeutic hypothermia is a promising treatment option that 




Additionally, patients who have experienced an AMI are at risk of a 10% fatality 
rate during hospitalization, and a 76% chance of developing chronic heart failure during 
the next 5 years [28][29][30][31].  
Ischemia Reperfusion Injury  
AMI is currently treated by methods of reperfusion, which aim to quickly restore 
blood flow to the oxygen-deprived myocardium. Reperfusion is the primary therapeutic 
goal for the treatment of AMI and has been shown to restrict the severity of infarction 
and even reduce mortality [24][25][26]. Paradoxically, clinical data has shown that 
significant myocardium damage can occur from blood reperfusion, accounting for up to 
25 to 50% of the resulting myocardial infarct size [32][33]. This is known as ischemia 
reperfusion (IR) injury [24][33]. After the occlusion has been removed, the patient is at 
risk of both temporal and permanent myocardial injury. The former can span 48 hours to 
several days, while the later refers to permanent necrosis of myocardial cells after 
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reperfusion [34][35]. There is currently no active therapy that prevents myocardial 
reperfusion injury in patients experiencing an AMI [28]. Most animal and human pilot 
studies have shown positive results, but a randomized controlled trial failed to replicate 
the outcomes [36].  
To improve patient outcomes, new therapeutic strategies are being investigated to 
reduce permanent damage caused by IR injury. One therapeutic strategy is known as 
post-conditioning and is performed using a balloon catheter that opens an occluded artery 
and alters reperfusion mechanically. Moreover, this thesis work will focus on a novel 
cardioprotective strategy using therapeutic hypothermia [13][37][38][39][40]. 
Existing treatments. Several clinical trials have failed to show that drug therapy 
can reduce infarct size by limiting reperfusion injury [24][41][42]. Examples of failed 
clinical trials for reducing reperfusion injury and reducing myocardial salvage include the 
use of Adenosine [43] and inhaled nitric acid [36]. Future efforts that aim to prevent 
reperfusion injury or salvage ischemia myocardium should focus on non-pharmacological 
approaches as well [43]. An example of a widely used non-pharmacological intervention 
procedure to treat AMI is known as percutaneous transluminal coronary angioplasty 
(PTCA). 
Applied using percutaneous transluminal coronary angioplasty (PTCA). In 
September of 1977, Andreas Grüntzig introduced and performed the first minimally 
invasive percutaneous transluminal coronary angioplasty (PTCA) in a patient. PTCA has 
since become the most widely used major intervention procedure to treat patients with 
angina and AMI [44][45]. PTCA offers a non-surgical treatment method for intervention 
in AMI, a primary source of mortality in western Europe and North America, and has 
recently improved its success rate since the introduction of stenting [46][47][48]. 
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Timely use of revascularization procedures, or reperfusion to an organ or body 
part suffering ischemia, has shown to contribute to decreased mortality rates in patients 
who have undergone percutaneous coronary interventions (PCI) in ST-segment elevation 
myocardial infarctions (STEMI) [49]. As of 2009, median costs for PCI procedures 
(including intervention procedure and hospitalization) were $19,349 [50]. 
Treatment to reestablish sufficient coronary blood flow after AMI using primary 
percutaneous coronary intervention (P-PCI) is performed using balloon angioplasty (Fig 





Figure 1.5. Primary percutaneous coronary intervention (P-PCI) performed using balloon 
angioplasty with stenting [51]. The occlusion is located in the artery network (a) and a 
guide is advanced through the femoral artery into the occluded vessel with the balloon 





These devices for treating AMI are designed to be used in emergency cardiac 
catheterization laboratories. Stents used are either bare-metal stents (BMS) or drug-
eluting stents (DES) [52]. Of these, Cobalt chromium DES’s exhibit the most favorable 
outcome to reduce AMI, stent thrombosis, and cardiac death rate [25]. 
a. b. c. d. 
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 Additionally, the use of post-conditioning (PC) is a moderately new 
revascularization procedure which is used to diminish IR injury by inducing transitory 
cycles of ischemia during the onset of reperfusion [53]. During this procedure, a PTCA 
balloon catheter is inserted into the femoral artery and advanced proximally to the 
occluded artery and is intermittently inflated and deflated per a predetermined algorithm. 
Although coupled with PTCA and PC procedures, external cooling blankets can result in 
side effects including increased infection risk, wound healing degradation, and patient 
discomfort from shivering due to unintentional overcooling [54][55]. 
Other treatments. Percutaneous transluminal coronary interventions (PTCI) have 
proven to be effective methods at improving heart function and diminishing the size of 
myocardial infarct [56]. However, clinical trials involving the use of PTCI with 
adjunctive therapies have failed to show positive results following myocardial infarction 
(MI) [57][58]. Other MI preventative treatments involve prescribing patients with 
antiplatelet P2Y12-receptor blockers prior to angioplasty procedures, which act to reduce 
vessel obstruction post PCI [56]. Still, clinical trials involving platelet inhibitors 
combined with PCI have failed to report positive results with PC [59][60]. MI outcomes 
will not be improved unless cardioprotective therapies surpass the effects of antiplatelet 
agents. Other treatment methods suggest the use of mild hypothermia coupled with 
sodium-hydrogen blockers that have helped to reduce infarction in rats when used with 
P2Y12 inhibitors [61]. A suggested solution to reducing MI is the development of an 
intervention that induces rapid cooling with platelet inhibitors during the time of 






Therapeutic Hypothermia (TH) aims to reduce normal tissue temperatures to 
improve patient outcomes [62][63][64].  
History. Ancient Egyptian, Roman, and Greek physicians used hypothermia to 
treat humans with trauma and hemorrhage [65][66], and was even used in 400 BC by 
Hippocrates who advised the use of snow and ice on wounded patients to reduce 
hemorrhage and bleeding [67]. TH was reintroduced in the 1940s to 1960s as a method to 
treat cardiac arrest patients [68][69][70], and was used as an effective method for organ 
transplantation, which was thereafter considered routine postoperative care [71][72]. 
Aside from the hospital, hypothermia has been used to salvage the brain in animals and 
humans succeeding cardiac arrest [63][64]. Hypothermia is recommended by the 
American Heart Association and the European Resuscitation Council to improve 
neurological recovery in comatose patients that have experienced a cardiac arrest [73].  
Hypothermia can be categorized as mild, moderate, severe, or profound, with 
temperatures ranging between 32-35 °C, 28-32°C, 20-28°C, and <20°C, respectively 
[74]. TH is mostly attributed to mild hypothermia due to its hemodynamic stability in 
animals and humans. Moderate hypothermia could induce atrial fibrillation, while severe 
hypothermia could induce ventricular fibrillation [74][75][76]. To effectively reduce 
infarct size and safely diminish reperfusion injury, myocardial temperatures should be 
between 32-34°C [13][77][78]. 
Existing treatments. Current TH treatment methods consist of methods using 
external cooling blankets, percutaneous transluminal coronary angioplasty, and 




External cooling blankets. Non-invasive technologies are also under 
development. A non-invasive surface cooling apparatus called ThermoSuit has been 
tested on animals to treat early phase AMI via whole body cooling. However, along with 
similar noninvasive cooling blanket techniques, it remains a challenge to effectively cool 
patients at a cooling rate of 3.0°C/hour without causing adverse-effects such as frequent 
wound infections and disturbed shivering [79][80][81]. Moreover, US domestic hospitals 
have lethargically implemented the use of TH in their cases involving postcardiac arrest 
patients [82]. This is considered partially a result of TH unfamiliarity amongst physicians 
and the inaccuracy of external cooling using blankets and ice bags, which are usually 
inaccurate at maintaining TH temperatures [83]. 
Endovascular whole-body devices. Patients undergoing endovascular whole-body 
cooling interventions to treat AMI experience whole-body hypothermia at 33⁰ C [13]. 
These procedures typically require a separate insertion in the femoral vein (Fig. 1.6) for 





Figure 1.6. Endovascular cooling device inserted in the femoral vein and positioned in the 
Inferior Vena Cava (IVC). Patients undergoing endovascular cooling interventions 
experience whole-body hypothermia at 33⁰ C [13]. Endovascular cooling methods 
maintain target TH temperatures more efficiently than conventional external cooling but 




Target temperatures of TH can be maintained more efficiently using endovascular 
cooling methods compared with conventional external cooling blankets [54].  Safety 
outcomes between endovascular and external cooling procedures are considered 
comparable, while endovascular cooling provides superior accuracy in sustaining TH 
target temperatures [85][86]. In comparison, endovascular whole-body cooling devices 
may maintain more accurate target temperatures but are unable to reach these 
temperatures quicker than conventional external cooling.  
Chilled Saline In 
Chilled Saline Out 
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Emerging treatments. Safe, rapid cooling of the heart is an important goal for 
physicians to effectively treat patients with AMI. Studies have shown that rapid 
hypothermia therapy (< 35°C) before reperfusion in patients with AMI can reduce infarct 
size by 37% [87][88][89][90]. This is known as Therapeutic Hypothermia (TH), which 
has shown feasibility for cardioprotection via methods of intravenous saline infusion and 
endovascular cooling [87][91]. The vast majority of AMI treatment methods involve 
whole-body cooling interventions, rather than heart-specific TH cooling devices, which 
are currently not on the market [92].  
Localized therapeutic hypothermia. Studies have demonstrated the use of 
minimally invasive cooling catheters (Fig. 1.7) designed to locally induce TH by 





Figure 1.7. (a) 3D representation of the left anterior descending artery modeled in 
Mimics from DICOM HH63 (HH = Human Heart) from the Visible Heart Lab, 
University of Minnesota. (b) Schematic illustration of a standard guide catheter 








Localized hypothermia has the potential to cool heart tissue rapidly following 
AMI, 3°C in 5 mins without the adverse-effects [93][94]. Nevertheless, the effectiveness 
of TH treatment for AMI, measured by myocardial salvage, will be impacted by the 
vascular structure with each patient (i.e. bifurcation patterns and vessel lengths and 
diameters). That vascular structure is akin to the internal design of an evaporator or a 
condenser, where each system, and analogously, each person is different.  
Studies performed by Otterspoor [13] studied the impact of intracoronary 
hypothermia in patients with acute myocardial infarction. During the occlusion phase, 20 
ml/min infusate was delivered at room temperature (22℃) proximal to the occlusion and 
the flow rate was adjusted to match a distal coronary artery temperature of 6℃ below 
body temperature. During the reperfusion phase (after occlusion removal), saline was 
infused at 16 ml/min at 4℃. Out of the ten patients enrolled in the study, six patients had 
occlusions in their LAD, one had an occlusion in the LCX, and three had an occlusion in 
the RCA. 
Another study employed 73 patients, where 53 experienced stable angina (SA) 
and 20 had signs of ST-elevation myocardial infarction (STEMI) [95]. Guide catheter 
infusions delivered saline at room temperature at 10-30 ml/min flow rates in the LAD and 
LCX arteries. The infusion catheter tip was fixed proximal to the occlusion and infusate 
was delivered at -5℃ below body temperature in the distal arteries. 
In a study performed by McGarvey [96], ten patients experiencing STEMI 
endured primary angioplasty (PPCI) by receiving intracoronary infusate at room 
temperature through a guide catheter. Average intracoronary temperatures were reduced 
to 3.4℃ below body temperature and infusate flowrates were delivered between 60 
ml/min and 100 ml/min proximal to the occlusion. A predetermined temperature of 30℃ 
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was set as a threshold to avoid the risk of hypothermia complications during infusate 
perfusions. Out of the ten patients included in the study, three occlusions were evident in 
the proximal LAD, two in the Mid-LAD, one in the LCX, and four in the RCA [96]. 
Advantages of localized cooling. In vivo trials reduced areas of heart tissue by 3℃ 
in 5 mins using 30 W of cooling [92]. Rapid, localized cooling of heart tissue generally 
does not impact core body temperatures [94], and provides approximately ten times the 
cooling rate to that of external cooling devices, offering ~1℃ per minute compared to 
0.1℃ per minute [97].  
A significant advantage to organ specific cooling is its ability to leverage the 
reduced thermal inertia, which results in rapid cooling of the myocardium. Since the 
product of mass and specific heat yield cooling capacity, it will be much quicker to cool a 
portion of a 310 gram heart than an entire 62 kilogram patient. Thus, cooling rates are 
significantly greater using localized cooling methods, which is a preferred method to use 
following an ischemia event [13][98][96]. Additionally, localized TH may serve as an 
effective co-therapy for angioplasty procedures.  
Disadvantages of localized cooling. Localized organ cooling is a relatively new 
therapy and requires a substantial amount of research to assess its impact on damage 
caused to heart muscles across a broad spectrum of patient-specific vascular structures. 
Large clinical trials are needed to replicate localized cooling results from isolated pig 
heart studies [13] and small trials treating patients with STEMI [96]. There are major 
differences between localized cooling results from artificial occlusions in pig hearts and 
AMI in humans [99]. Lastly, optimal TH intracoronary temperatures have not been 
established for effectively reducing ischemia reperfusion injury [74][100]. Table 1.1 












































Note. *IVC = Inferior Vena Cava, *LMCA = Left Main Coronary Artery, *ASTT = 




What others have done to examine the biophysics of heart cooling. Studies 
involving the biophysics of heart cooling remain elusive, specifically, the biophysics of 
coronary artery cooling following MI. Experimental studies have explored myocardial 
protection techniques using computer simulations to examine topical cardiac cooling 
[101], as well as conjugate heat transfer by computationally pumping cold liquid through 
the major cardiac chambers [102]. 
The majority of computational cardiac biophysics research targeted towards the 
coronary arteries have focused primarily on computing and visualizing hemodynamics 
(i.e. coronary blood shear, pressure, and velocity) [4][103][104][105], coronary artery 
fractional flow reserve (FFR) [106], and lumped parameter modeling [75][107]. A 
lumped parameter model is a mathematical model that describes the physiological 
constraints of a system using systematic mathematical calculations [108]. To our 
understanding, there is no explicit literature analyzing the biophysics of localized cooling 
in patient-specific coronary arteries. 
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What is not well understood? The structural properties of the heart and its impact 
on thermal fluid behavior are poorly understood [92], [94], [109], [110]. A study 
performed by Otterspoor, 2018 involved the use of lumped parameter modelling to 
mathematically predict myocardial temperatures from intracoronary arterial temperature. 
However, higher fidelity and more complex calculations using computational fluid 
dynamics (CFD) modelling were not used, which could provide clinically significant 
physics-based models representing patient-specific vascular structures. CFD modelling 
methods are ideal tools to help determine the preferred flows and temperatures of 
intravascular GuideLiner® infusions for patient-specific procedures [13]. 
Problem Statement 
Significance of work. The link between thermal fluid behavior and the structural 
geometry of the coronary arteries has not been sufficiently studied [95], [111]–[113]. 
Thermal fluid models of heart cooling, as well as models that predict arterial blood and 
myocardial tissue temperatures in patient-specific hearts do not currently exist [13]. 
Objectives of study. In this study, patient specific LAD and LCX artery models 
are used to help determine the impact of thermal fluid behavior from TH treatment 
methods [13]. A new thermal modeling approach is introduced that could provide a better 
understanding of the biophysics of AMI during TH, as well as provide insight to guide 
more efficient TH device designs and operation parameters [92]. 
We aim to gain insight in determining distinguishable temperature behavior 
between six patient-specific LAD and LCX arteries by comparing temperature 
distributions of different coronary artery geometries and surface area variations. We also 
seek to reveal the effect of catheter flow rate on patient-specific temperature distributions 
in each LAD and LCX artery vasculature. The evaluation metric for comparison between 
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models will be the measured distance of TH fluid temperatures along the fluid pathway. 
Success will be the result of TH fluid temperatures exiting the artery outlets.  
The objective of this study is to create thermal fluid models of TH in six patient-
specific human LMCA’s predicting arterial blood temperatures for a variety of hearts and 
catheter infusion flow rates in the proximal LAD and LCX vasculature. CFD models can 
help determine and qualitatively analyze temperature distributions in the LMCA’s. They 




























 The following chapter provides the biophysics background and describes the 
fundamental governing equations required to solve fluid mechanics and heat transfer 
problems in a human heart vascular network. This chapter will discuss the governing 
equations used in our computational models including conservation of linear momentum and 
conservation of thermal energy. The end of the chapter will describe an equation for solving 
dynamic viscosity as a function of shear rate, hematocrit, and temperature. 
Laminar Flow: Conservation of Linear Momentum 
Governing equations. The Navier-Stokes equations describe the conservation of 
linear momentum for fluid flow in three-dimensional space, and are represented in 








































































                            (2.3) 
where 𝜈 represents the kinematic viscosity having the form 
𝜇
𝜌
, where 𝜇 is the dynamic 
viscosity as a function of temperature and shear rate. 
Blood will be considered as an incompressible, Newtonian fluid, since the viscosity 
is dependent on shear rate [139][140], with a constant (or average) shear rate assumption. 
As a result, viscosity will only vary with temperature, providing there is coupling between 
the energy and Navier-Stokes equations. This concept will be described in further detail 
later in this chapter.  
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Pulsatile flow is a natural phenomenon that occurs in physiological systems, such 
as the human respiratory and circulatory system [17]. However, the heat transfer coefficient 
for steady and pulsatile flow are equivalent [115][116], and studies have shown that 
pulsating effects have no impact on heat transfer in blood flow [117][118]. Therefore, 
pulsating flow effects were disregarded and steady state simulations were used to solve for 
ABT distributions that would typically reflect pulsatile flow conditions.  
  Steady state flow occurs when the fluid properties, such as temperature and mass 
flow rate, are unchanging over time for any single point in the system. Steady state 
simulations are also computationally cost efficient since they typically complete using 
significantly less CPU time than unsteady state simulations. For this reason, steady state 
CFD simulations are typically used as a starting point to verify that physics conditions and 
fluid properties are accurately solved [119]. Therefore, for this research, steady state, 3-
dimensional laminar flow will be assumed.  
Governed by the laminar Navier-Stokes equations of conservation of linear 
momentum (2.4a), and the continuity equation of conservation of mass (2.5), the equations 




 =  𝜌𝑔 −  𝛻𝑝 +  𝜇 · 𝛻2𝑉             (2.4a) 
𝛻 ·  𝑉 = 0          (2.5) 
where 𝑉 is the fluid velocity, 𝛻 denotes the operator, ρ is the density of the fluid, 𝑔 is 
gravity, p is the pressure of the fluid, and μ is the dynamic viscosity of the fluid. Equation 
2.4a is the more frequently seen version of the Navier-Stokes equations. However, for 





 =  𝜌𝑔 −  𝛻𝑝 +  𝛻 ⋅  𝜇(𝛻𝑉)           (2.4b) 
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where the viscous stresses inside of the divergence operator come from 𝜇 times the 
velocity gradient. Since the Navier-Stokes equations indicate a force per unit volume, the 
viscous force (per unit volume) is resultant of viscous stress (per unit area), where area 
forces are integrated to volume forces which are reconciled through the divergence 
theorem [121]. The viscous terms are then split between equations 2.4a and 2.4b, 
resulting in the external divergence operator as seen in Eq. 2.4b [115]. 













?̂?       (2.6) 
where ?̂?, 𝜃, and ?̂? are unit vectors associated with their corresponding r, 𝜃, and z 
directions in cylindrical coordinates. Equations 2.1 to 2.5 represent the foundation of all 
computational fluid dynamics (CFD) modeling. Chapter 8 describes the innovative 
approach of this work and limitations of the before mentioned assumptions. 
Laminar Flow: Conservation of Thermal Energy with constant wall temperatures  
Governing equations. The thermal energy equation for an incompressible fluid 
that satisfies the continuity equation (Eq. 2.5) can be described as a 3-dimensional problem 
with no kinetic energy or time derivative of pressure 
𝜕𝑝
𝜕𝑡










] = 𝑘 [
𝜕2𝑇
𝜕𝑥2
] + 𝑘 [
𝜕2𝑇
𝜕𝑦2
] + 𝑘 [
𝜕2𝑇
𝜕𝑧2
]                  (2.7) 
where the specific heat, 𝐶𝑝, and thermal conductivity, k, are assumed constant, T is the 
absolute temperature, and the terms on the right side of the equation represent the rate of 
thermal diffusion. 
 Eq. 2.7 is coupled with Eq. 2.4 because the viscosity, 𝜇(𝑇) is a function of 
temperature, where T is determined from Eq. 2.7. Therefore, Eq. 2.4 and Eq. 2.7 are 
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coupled to solve for each iterative temperature and viscosity along the fluid flow path, 
respectively. These values are then used as inputs to solve for fluid flow in the Navier-
Stokes equations (Eq. 2.1 - 2.3). Appendix A contains detailed derivations of the fully 
developed velocity profile, energy balance, and the temperature dependent heat source 
equation in cylindrical coordinates. Additional information regarding CFD modeling 
methods will be discussed in greater detail in Chapter 3. 
Post-Processing 
 The average bulk temperature (ABT) in fluid flow is the mean temperature of the 
fluid’s cross section [115]. For complicated LMCA networks, the ABT changes in the 
direction of flow and is a critical post-processing component for determining LMCA 
outlet temperatures. The rate of energy flowing through a cross section is considered 
equivalent to the energy rate travelling through said cross section with a constant fluid 
temperature [115]. Therefore, the flow rate of thermal energy of the fluid can be 
expressed as the following: 
?̇?𝑓𝑙𝑢𝑖𝑑 = ?̇?𝑐𝑝𝑇𝑚 = ∫𝐴𝑐 
𝜌𝑢𝑐𝑝𝑇(𝑟, 𝑥)𝑑𝐴𝑐        (2.8) 
where 𝐴𝑐 is the cross-sectional area, 𝑇𝑚 is the mean temperature, 𝜌𝑢 is the mass flux, 
where 𝑢 has (𝑟, 𝑥) dependence, and 𝑐𝑝𝑇(𝑟, 𝑥) is the internal energy per unit mass. Thus, 







2 ∫ 𝑢𝑇(𝑟, 𝑥)𝑟𝑑𝑟
𝑟𝑜
0
         (2.9) 
where 𝑢𝑚 is the mean velocity, and 𝑟𝑜 is the radius of the cross section of interest. 
Properties 
When non-isothermal fluids experience a temperature change, the material 
properties, such as density and viscosity, are also subject to change [122]. Determining 
the material properties of a fluid is a critical step in solving fluid dynamics problems. The 
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physics of fluid dynamics simulations hinge upon material properties that accurately 
reflect the properties of the problem being solved.  
Dynamic viscosity. Dynamic viscosity (µ) for the mixed blood and distilled 
water in the LAD and LCX arteries was modelled using an equation derived by Cheung 
et al. 2000 [123]. The model was used in our study to calculate the viscosity of the mixed 
fluid between 0 and 40 °C. The Dynamic viscosity is a function of shear rate, hematocrit, 
and temperature, and can be expressed as: 





]     (2.11) 
where the shear rate (Υ̇), hematocrit value (Hct), and mean temperature (𝑇𝑚) are 
independent variables and the dynamic viscosity is the dependent variable for this 
solution. The remaining coefficients, λ, ƞ, α, ϕ, β, and Є, represent predetermined values 
derived by Cheung et al. 2000 [123]. A total mixed Hematocrit value was determined for 
each of the catheter flow rates, and an average shear rate was calculated for each of the 
six LMCA models. Therefore, equation 2.11 is simplified to become: 
µ(𝑇𝑚) =  𝐶 ⋅ [𝛼 +
ϕ
1+𝑓(𝑇𝑚)
]    (2.12) 
where 𝐶 is a constant, and 𝑓(𝑇) is how equation 2.7 is coupled to the Navier-Stokes 
equations (2.1 to 2.3). The common Newtonian form of the Navier-Stokes equations (Eq. 
2.4) is now extended to non-Newtonian fluids, which now requires the energy balance 
equation to solve for temperature. 
The treatment of hematocrit and shear rate effectively prescribes a vasculature-
specific Newtonian flow for each LMCA simulation. Additionally, full non-Newtonian 







 A number of computational methods were required to solve the thermal fluid 
modeling work described this thesis. The modeling workflow and CFD simulation 
process is described in detail. 
Materialise Mimics® Workflow 
 Mimics (Materialise’s Interactive Medical Image Control System) Innovation 
Suite 20 is one of Materialise’s high-end processing tools used to create 3D models from 
2D cross-sectional computed tomography (CT) or magnetic resonance imaging (MRI) 
medical image stacks [126].  
DICOM Image Sets to 3D Vasculature Creation 
The images employed in this study consist of image stacks known as DICOM 
(Digital Imaging and Communications in Medicine) image files [127]. DICOM images 
are typically attained from hospitals and/or doctors and are used to analyze specific 
organs of the body. DICOM defines the international standard for format use of medical 
images that satisfy the quality and requirements to transmit, store, and process clinical 
use imaging information [127]. For this study, the DICOM image sets consisted of CT 
angiography axial image stacks with an average slice thickness of 0.942 mm ± 0.3, a 
plane resolution of 512 x 512 pixels, and an average pixel resolution of 0.377 mm ± 
0.085. The source of where the DICOM images came from and rationale for selecting 
specific human heart models is discussed in Chapter 5.  
 DICOM files were imported into Mimics Innovation Suite 20 (Mimics®) as 
stacks of axial images in the XY plane (axial plane). Mimics® interpolates the image 
stacks to produce a 3D impression of the model (Fig. 3.1) by creating images in the XZ 




Figure 3.1. 3D volume rendering window in Mimics® of the LMCA segmented from 2D 
CT angiography image scans of HH55. The views in the window pane consists of the 
coronal (a), axial (b), sagittal (c), and the 3D rendering window (d). Green highlighted 
pixels (c) represent the segmented blood flow path of the artery network. The fully 
segmented 3D model (d) represents a patient-specific structure that can be exported in 




 Segmentation approach. CT scanners produce medical images that exhibit 
grayscale information. Mimics utilizes the grayscale information by enabling the user to 
highlight individual grayvalues, known as Hounsfield units, within each image [126]. 
Grayvalues are numbers that represent each pixel on an image that correlate to both the 
density and shade (black, white, or gray) of the pixel. Mimics groups together similar 
grayvalues so that an image can be segmented; a process used to convert anatomical 
image data sets to 3D models. During segmentation, the vasculature of interest for each 
pixel of the data set images was highlighted. This data was then translated from the 
segmented images to create a 3D model of the accentuated vasculature [126]. This 
method is known as thresholding and was used to create accurate 3D representations of 






 STL format. Mimics® models were exported in stereolithography (STL) format 





Figure 3.2. DICOM to SolidWorks editing workflow. DICOM images were attained from 
the Visible Heart Lab, University of Minnesota (Step 1) and imported into Mimics for 3D 
model segmentation and 3-matic smoothing (Step 2). The Mimics/3-matic models were 
exported in binary STL format (Step 3) and imported into SolidWorks for inlet/outlet 




STL files represent the surface geometry of 3D objects using a triangulated 
surface mesh without representing the color or texture of the object of interest. The 
surface geometry of STL files are encoded with triangular configurations such that there 
are no gaps or overlaps in the outer-surface portrayal, or shell, of the model’s vasculature. 
This meshing structure allows for a simple, yet accurate representation to match most 
complex geometry structures. STL files are generated as compact binary versions of a 
model, which can be imported into 3D engineering programs for post processing [128] 
and computer aided design (CAD) manipulation [126]. 




2.    Mimics & 3-matic 1.    DICOM 3.    STL 
4.    SolidWorks 
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Materialise 3-Matic Model Smoothing 
 The Mimics® STL files were exported into Materialise 3-matic, an extension of 
Materialise’s engineering software tools that enable detailed design manipulation of STL 
files. This software was used to perform advanced editing and remeshing of the STL 
LMCA models, such as trimming sharp edges and filling holes in the mesh that were 
created during the segmentation process. 
SolidWorks Editing 
With an STL file formed by Mimics and the original DICOM data set, the binary 
STL files from the LAD and LCX heart models were imported into a 3D computer-aided 
design (CAD) modeling and editing tool, SolidWorks®, where the inlet and outlets were 









Figure 3.3. With an STL file formed by Mimics and the original DICOM data set, a 3D 
modeling and editing tool, SolidWorks® was used to orthogonally trim the inlet and 
outlets of each LAD and LCX artery model. The following HH55 LCX model contains a 
single inlet and 33 outlets, however, the number of outlets varied with each LAD and 




When Mimics® STL files are exported into SolidWorks®, the geometry of the 
model slightly changes, which leads to an increased risk of surface repair and meshing 
issues. Each software tool that is used to refine and edit the model contributes to a 
possible surface meshing issue, which could cause simulation errors in computational 
modeling work. Therefore, these errors should be identified and remedied in each 
software tool. For example, holes in the surface mesh were identified in 3-Matic and 








Brief Description of Siemens STAR-CCM+ Workflow 
Finite volume method. The Finite Volume Method (FVM) is a computational 
method used to solve complex problems involving partial differential equations (PDE’s). 
The FVM uses a discretization process that interprets a set of governing equations 
defined on a computational domain. The domain is discretized into a system of structured 





Figure 3.4 The physics space (1) in a simple bent tube is comprised of a grid that 
encompasses the computational domain. At each node (2), the governing equations in 
algebraic form are created. If we combine 1 and 2, a system of equations can be used in 




The FVM approximates a formation of ordinary differential equations (ODE’s) 
that describe the computational mesh comprising of the minute control volumes (i.e. 
cells, elements) [114][130]. These equations employ iterative solvers that are able to 






accurate solution can be obtained by refining the mesh within the boundary conditions, 
which provides a more precise assessment of the ODE solvers in the physics domain. 
FVM mathematics. Conservation laws from the Navier-Stokes equations are 
applied in integral form when solving FVM [131]. A succession of finite control volumes 
permeates the computational domain and are executed in the physical space using 
identical coordinate systems. To describe how FVM works mathematically, consider the 
incompressible continuity equation (Eq. 2.2) from Chapter 2, where 𝛻 · 𝜈 = 0. 




 𝛻 · 𝑣 𝑑𝑉 = 0        (3.1) 
where 𝑣 is the fluid velocity, dV is the volume element, and 𝑣𝑖 is the control volume 
integrated over the surface. Applying the divergence theorem, we obtain: 
∮
𝑆𝑖
 𝑣 · 𝒏𝑑𝑆 = 0       (3.2) 
where 𝒏 is the unit normal to the volume element and dS is the surface area of the 
volume element. Thus, Eq. 3.2 represents a boundary integral typically used in FVM 
analysis describing the continuity for a control volume [132].  
The governing equations described in Chapter 2 are discretized into algebraic 
equations that are solved across the computational domain at discrete locations to 
numerically represent fluid flow and heat transfer values. The mesh representing the 
computational domain is a three-dimensional discretization that should represent 
independence of the governing equations from additional mesh refinements. 
Boundary conditions applied to FVM. To get a better understanding for how 
the Navier-Stokes (NS) and Thermal Energy equations work together to solve CFD 




Characteristic CFD Boundary Conditions and Relationship to Navier-Stokes and 
Thermal Energy. 
Boundary Condition Navier-Stokes Thermal Energy 
In ?̇? 𝑇𝑖𝑛 








The NS boundary condition entering our inlet region represents flow that is fixed 
to typical mean flows, while NS at each of our outlet regions represents P = 0, meaning 
there is no backpressure acting on our system at the outlets. NS for the walls signify a 
zero velocity no slip boundary condition represented by a fixed (stationary) wall. The 
Thermal Energy entering our inlet region represents physiological blood temperature at 
the artery inlet and chilled saline temperatures at the GuideLiner® inlet. Exact 
temperatures are listed in Chapter 4. Thermal Energy exiting our domain is built on our 
assumption of having sufficient vascular lengths such that the gradient along the vessels 
are negligible. Lastly, our Thermal Energy boundary condition acting at the walls 
represents a constant, isothermal physiological body temperature. 
Since NS is especially useful in solving fluid dynamic simulations, while thermal 
energy is utilized to solve heat transfer phenomena, the two can be coupled together to 
denote distinct boundary conditions used in solving our CFD models. Although NS and 
Thermal Energy equations work together in CFD heat transfer simulations, they are 
contingent upon dynamic viscosity, 𝜇, and its associated temperature.  
More complicated thermal boundaries could be envisioned in lieu of 𝑇𝑤𝑎𝑙𝑙 =
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡, however, at present, no work yet exists even for isothermal walls. Therefore, 
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the effect of vascular branching and concentrated heat sources from close branches can 
be ignored.  
Mesh convergence. A mesh convergence analysis is required to attain an 
optimum mesh. If the mesh contains large cells, the number of cells in the mesh would be 
minimal (Fig. 3.5) and the temperature would vary dramatically below the optimum 





Figure 3.5. Mesh convergence analysis comparing the number of cells in a mesh and a 




On the other hand, if the mesh contained very small cells so that the number of 
cells in the mesh approached infinity, the mesh would require extensive computational 
times and would only vary the resultant temperature slightly. Therefore, a mesh 
convergence analysis is required to obtain an optimum number of cells so that resulting 



















Number of Cells in Mesh 
Optimum Number of Cells 
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Siemens STAR-CCM+. Siemens STAR-CCM+® is a commercially available 
finite element analysis software platform used to solve complex and accurate physics 
simulations including fluid dynamics, heat and mass transfer, solid mechanics, and 
related phenomena [133]. All of the models in this study were executed using STAR-
CCM+ (version 13.04.010), where FVM was employed as a discretization process that 
transformed PDE’s into explicit algebraic equations so that numerical solutions could be 
determined. In Chapter 6, the computational domains will be described as a mesh with 
appropriate discretization for solving fluid flow and temperature distributions in patient-
specific coronary arteries. 
A synonymous description for STAR-CCM+ modeling is the term computational 
fluid dynamics (CFD), which refers to the use of high-speed computers for computing 
mathematical simulations of real-life physical events or processes [114]. The goal of 
CFD software packages is to analyze and predict fluid flow, heat and mass transfer, and 
chemical reactions using numerical simulations to solve for conservation of mass, 
momentum, and energy [114]. CFD analysis offers a comparable alternative to traditional 
experimentation and testing by providing a low cost, finite element model substitution. 
Regardless of which software package is used for CFD simulations, the same approach is 
required to simplify and solve for the solution. The typical CFD workflow is best 






Figure 3.6. The general CFD modeling approach that describes the necessary steps for 




 All CFD simulations use a similar approach to Fig. 3.6. The first step is to clearly 
define the aims of the simulation prior to defining the geometry and creating the mesh. 
Additionally, one must ensure that the correct physics models are employed in the solver, 
and that the solution fully converges. Since CFD modeling provides an alternative to 
experimental development, CFD studies must always be scrutinized and compared with 
experimental results and published data to validate each model’s credibility [134].  
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Computer hardware. All Mimics® modeling, SolidWorks® editing, and STAR-
CCM+® simulations were executed using an XI M Tower 2P64X Workstation with a 
3.70 GHz Intel Xeon Quad-Core processor and 32.0 GB of RAM running Windows 10 
Pro 64-bit Operating System. This workstation will be referred to in Chapter 6 as 
workstation 1 (WS1). Minor post-processing manipulations including custom plane 
creation along the artery pathway, cross-sectional ABT reports, and scalar temperature 
and streamline images of the LMCA were executed using a Dell Inspiron 15 7000 Series 
with a 1.60 GHz Intel Core i5 processor and 8.0 GB of RAM running Windows 10 
Education 64-bit Operating System. This workstation will be referred to in Chapter 6 as 
workstation 2 (WS2). 
Modeling objective. In summary, this chapter describes the workflow from 
obtaining DICOM image files to creating patient-specific 3D LMCA models for CFD 
simulations. Since the goal is to create thermal fluid models of TH in six patient-specific 







In Vitro Methods 
In Vitro Setup 
 
This chapter presents the in vitro mock loop, including the equipment and 
calibration methods used to measure temperate and flows in a cardiovascular system. The 
objective of the in vitro mock loop testing was to use the GuideLiner® outlet temperature 
and flowrate data as inlet conditions in our computational fluid dynamics (CFD) models.  
This in vitro study replicated physiological blood flow and temperature conditions 
and provided realistic data to use in our CFD simulations. The mock loop system 
provided a rapid and accesible phyioslogical enviroment to accurately test and record the 
outlet temperatures and flow rates for the 7F Cordis Vista Brite® guide and guide 
extension in conditions similar to in vivo. 
The following bullets are steps needed to obtain this objective: 
 Calibrate thermocouples, pressure sensors, and flow meters. 
 Update and execute mock loop protocol. 
 Place the Cordis Vista Brite® 7F guide catheter in the mock loop and measure 
Vascular Solutions GuideLiner® outlet temperatures for a variety of flowrates 
using distilled water.  In this chapter, the guide catheter will be called the 
“guide” and the GuideLiner® will be called the “guide extension”. 
Mock loop geometry. An in vitro mock loop from Merrill et al. [93][94] was 
rebuilt and modified to simulate the cooling performance of a standard catheter in the left 
main coronary artery (LMCA) vasculature (Fig. 4.1). The in vitro loop comprises of 
Tygon tubing networks, valves, and fittings that represent a controlled mock loop of the 




Figure 4.1. Schematic of modified coronary mock loop showing catheter path and mock 
vessels [93]. The guide (represented by solid blue line) is inserted into the femoral 
insertion sheath and advanced through the glass aorta into the LMCA ostium. The table at 





The cardiovascular mock loop system circulates distilled water at physiological 
flows, pressures, and temperatures through a glass aorta. A second portable loop system 
pumps distilled water through an external heat exchanger and into the proximal hub of 
the guide. The guide was inserted into an insertion sheath through the femoral artery 
access point of the glass aortic arch and advanced and fixed at the ostium of the LMCA. 
A full-size glass replica model of the aortic arch (Vasodyn, Freeville, NY) was 
positioned at the center of the test loop (Fig 4.2), and from it stems left and right coronary 
artery access points, as well as a femoral artery access point for blood (distilled water) 







Figure 4.2. Image of coronary mock loop showing catheter path and mock vessels. Note: 
Thermocouple (TC), common carotid artery (CCA), and left main coronary artery 
(LMCA). Flow from the large reservoir is pumped through a flow meter before entering 
the Tygon tubing as proximal Aorta flow. Flow enters the Aortic arch and disperses into 
the coronary artery ostia where it continues to the left main coronary artery (LMCA) and 
the guide extension outlet. Aortic flow exits through the common carotid artery (CCA) 




 Rather than a glycerol water mixture, which more closely resembles blood 
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fluid in the in vitro mock circulatory loop was due to the forced convection parameters 








      (4.2) 
 
 Where  𝜌 is density (
𝑘𝑔
𝑚3
), 𝑉 is velocity (
𝑚
𝑠
), 𝐷 is diameter (𝑚), 𝜇 is dynamic 
viscosity (𝑃𝑎 ⋅ 𝑠), 𝐶𝑝 is specific heat (
𝐽
𝑘𝑔⋅𝐾




The Reynolds number is a dimensionless value that describes the ratio of inertial 
to viscous forces and characterizes laminar (Re < 2300), transient (2300 < Re < 4000) or 
turbulent flow (Re > 4000) acting in a fluid [115]. The Prandtl number is a dimensionless 
parameter that characterizes the ratio of diffusion for momentum with respect to heat 
within a fluid [116]. The dimensionless values for Equation 4.1 and 4.2 are compared to 




Table 4.1. Dimensionless values for Reynolds and Prandtl numbers assuming 68.85 
mL/min inlet flow rate and 0.003m inlet artery diameter. 
Fluid Re Pr Re x Pr 




487 7.0 3404.2 
2.05 




The difference in dynamic viscosity between the blood (0.003 Pa⋅s) and distilled 
water (0.001 Pa⋅s) resulted in a 100.15% overall difference in Re. However, a small 
difference of 2.05% resulted between comparing (Re) x (Pr) of the blood and distilled 
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water. Since these latter differences are small, the distilled water should closely predict 
warming. Therefore, the distilled water was chosen for ease of use in this pilot work.  
A large reservoir containing distilled water (Fig. 4.3) is circulated and maintained 
at physiological temperatures (37⁰ C ±5) using an immersion heater (George Ulanet Co. 
Newark, NJ) controlled by a temperature feedback controller (Cole-Parmer, Vernon 
Hills, IL) and peristaltic circulation pump (Ismatec SA, Glattbrugg, Switzerland). A 
custom dampening cylinder is secured downstream to the peristaltic pump to reduce 





Figure 4.3. Continuation of Fig. 4.2 showing catheter path and mock vessels. Distilled 
water is heated in the reservoir and pumped into circulation via the peristaltic pump. 
Flow to the common carotid artery (CCA) and left main coronary artery (LMCA) can be 




Flow rates. Distilled water was used as the chilled infusate flow through the 
catheter at 10 mL/min to 90 mL/min flowrates, as well as the blood throughout the 
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mock circulatory loop. Flow was measured at various locations throughout the loop using 
two turbine flow meters (McMillan, Georgetown, TX), and a transonic flow meter 
(Transonic Systems Inc., Ithaca, NY). Equipment specifications and employed use for 
each flow meter are listed later in this chapter.   
To circulate and measure blood flow about the catheter in the coronary lumen, a 
Tuohy Borst Adapter (Fig. 4.4) with side port (Qosina, Ronkonkoma, NY) was connected 





Figure 4.4. The Cordis® catheter enters the ostium of the LMCA and the guide extension 
is advanced 8.5cm through the Tuohy borst adapter (TB Adapter), out of the catheter, and 
positioned in tight fit tubing. The fittings and catheter are insulated (not shown) after 
assembly. The “To Reservoir” label represents flow advancing towards the LMCA flow 
meter and into the mock loop reservoir. The “To Graduated Cylinder” label refers to 
infusate flowing towards the reservoir (or graduated cylinder), which is used to measure 




The sideport redirected coronary flow to a turbine flow meter (McMillan, 
Georgetown, TX) and into the large reservoir. The guide extension was advanced 8.5 cm 
out of the catheter and through the Tuohy Borst outlet. Tight fit tubing extended the guide 
extension and a type-T thermocouple was positioned 3 cm distal to the Touhy Borst 
TB Adapter w/Side Port 
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outlet and used to measure the temperature of the chilled infusate leaving the catheter. To 
ensure that average bulk temperatures were being measured, the entire flow path would 
be insulated from the exit of the GuideLiner® to the thermocouple, and would 
incorporate an in-line static mixer directly upstream of the thermocouple. For this work, 
the distance between the distal tip of the GuideLiner® and the temperature measurement 
point was minimized, which reduced heat loss and the need for insulation, and the fittings 
between the distal tip and temperature sensing location mixed the fluid at the point of the 
thermocouple. 




Critical flowrates and locations in mock circulatory loop. 
Location in Mock Loop Flow rate (ml/min) Reference 
Aorta 3500 ±150 [93] 
LMCA 145 ± 15 [10][11][12] 




Temperatures. Type-T thermocouples (Physitemp, Clifton, NJ and Blaze 
Technical Services, Stow, OH) were used to measure the catheter inlet and outlet, aorta, 















Make and sizes of thermocouples used to measure guide inlet, guide extension outlet, 
heat exchanger, and aorta temperatures. 











Physitemp MT26-2 HT 0.018” 2 cm 5 ft 
Heat 
Exchanger 
Physitemp MT26-2 HT 0.018” 2 cm 5 ft 
Aorta (Core) Omega TMQSS 040G 0.040” 6 in N/A 




Type-T Thermocouple accuracy as rated by the manufacturer is ±0.1°C. If noise 
or differences in simulation results for ABT are without the range of ±0.1°C then the 
results will not be accurately measured and values within this range will be disregarded. 
A high-accuracy pressure transducer (Cole-Parmer, Vernon Hills, IL) measured 
the pressure entering the aorta, and all instrumented measurement data was recorded 
using LABVIEW (National Instruments, Austin, TX) DAQ software. 
A total of 5 thermocouples were used in the mock loop system to measure the 
temperature at the catheter inlet and outlet, Aorta (core body temperature), chilled 
distilled water leaving the heat exchanger, and the Ambient (room) temperature. The 
mock loop core temperature, 37℃, was regulated by the reservoir heater and LabView 
control algorithm and was measured using a type-T thermocouple positioned upstream to 
the LMCA ostium in the glass aorta. The external cooling console (Fig. 4.5) was set to 
0℃ and pumped the chilled distilled water through a heat exchanger and into the proximal 







Figure 4.5. Internal view of custom built portable cooling console. The peristaltic pump 
(a) circulates flow from a small reservoir to the heat exchanger (b). Distilled water is 
chilled through the heat exchanger and advanced into the mock circulatory loop (4) by 




Chilled flow entering the proximal hub of the Cordis catheter was pumped using a 
custom built portable cooling console. The portable cooling console was mounted on a 
cart for easy maneuverability and Tygon tubing was used to join the cooling console to 
the catheter inlet and the rest of the components. This cooling console was used to 
circulate chilled saline (distilled water) at 10 ml/min to 90 ml/min through the catheter by 
first chilling the distilled water to 0⁰ C. The chilled infusate is pumped from a small 
reservoir to the catheter via a peristaltic pump (Watson-Marlow Fluid Technology Group, 
Wilmington, MA). A thermoelectric chiller (Custom Chill Inc., Philadelphia, PA) and a 
flat plate heat exchanger (GEA PHE Systems NA, York, PA) is used to chill the infusate 
to the desired temperature, 0℃.  
 
 
1a. Flow from 
Reservoir 
a. Peristaltic  
Pump 
b. Heat Exchanger 
(HX) 
1b. Flow from  
Peristaltic Pump 
2. Cold out to Chiller 
HX 
4. Chilled Flow 
to Mock Loop 




 Various equipment was used for the mock loop system, including flow meters, 
pressure sensors, thermocouples, pumps, fittings, and computer hardware. This section 
describes the make and models, calibration ranges, and medical devices used in the mock 
circulatory loop system. 
Make and models. Table 4.4 lists the makes and models of the equipment used to 






Make and model of flow meters, thermocouples, and pressure transducer used in mock 
circulatory loop system. 
Description Instrument Make & Model 
Coronary Flow Turbine Flow Meter McMillan Co., Georgetown, 
TX, S/N 11744 
Core Flow Turbine Flow Meter McMillan Co., Georgetown, 
TX, S/N 1616 
Cath. Inlet & Outlet, 
HX, ambient temp 
Type-T Thermocouples Physitemp, Clifton, NJ 
Aorta (core) temp Thermocouple Omega, Norwalk, CT 
Aorta Pressure Pressure Transducer Cole Parmer, Vernon Hills, 
IL, 68075-32 




A description of the peristaltic pump, Tuohy Borst adapters, and full-size glass 












Make and model of peristaltic pumps, glass aorta, and Tuohy Borst adapters employed in 
the mock circulatory loop. 
Description Instrument Make & Model 
Circulatory Pump Peristaltic Pump Ismatec, Glattbrugg, Switzerland 
Infusate Pump Peristaltic Pump Watson-Marlow, Wilmington, MA 
In-Circuit 
Dampener 
Custom Dampener FocalCool, LLC, Mullica Hill, NJ 
Aortic Arch Full-Size Glass 
Aorta 
Vasodyn, Freeville, NY 
LMCA Tuohy Borst 
Adapter w/Sideport 





The immersion heater used to heat the large reservoir (George Ulanet Co. 
Newark, NJ) was controlled by a temperature feedback controller (Cole-Parmer, Vernon 
Hills, IL) connected to a Thinkpad Ultrabook Intel core I5 vpro that was automated using 
LabVIEW (National Instruments Co., Austin, TX) data acquisition (DAQ) software.  
Range. Each thermocouple was calibrated to a confidence range that 
corresponded to a specific physiological temperature local to its intended use. For 
instance, the thermocouple for the aorta was calibrated for a confidence range between 
35℃ and 38℃, which was used to measure core body temperature, 37℃. The confidence 





Operational ranges for each thermocouple used in the mock loop system. 
Thermocouples: Range (℃) Confidence Range (℃) 
Cath Inlet Temp. -1.0 - 15 -1.0 - 18 
HX Outlet Temp. -1.0 - 15 -1.0 - 18 
Ambient Temp. 15 - 25 17 - 28 
Aorta (core) Temp. 35 - 38 32 - 38 






Akin to the predetermined thermocouple ranges, the flow meters were also 





Operational ranges for each instrument used to measure flow rate and pressure. 
Flows: Range Confidence Range 
Aorta 3000 – 4000 ml/min 1000 – 4000 ml/min 
Coronary 70 – 200 ml/min 82-183 ml/min 
Pressures: Range Confidence Range 
Catheter 
Inlet 
0 – 30 psi 7-18 PSI 




Calibration and precision. Calibration methods were performed for the 
thermocouples, flow meters, and pressure sensors. The thermocouples were calibrated in 
a chilled liquid bath (Thermo NESLAB, Oak Park, IL) consisting of 50% glycerol and 
50% distilled water so that 0℃ temperatures could be reached. Flow meters were 
calibrated using gavimetric methods and pressure sensors were calibrated using known 
water column heights. All sensor calibrations were within the manufacturer 
specifications.  
The tips of the thermocouples were positioned ~1.5 inches into the chiller bath 
solution and the liquid bath ranged between -3℃ and 40℃ as LabVIEW was used to 
record 60 temperature data points (1 point per second) for each thermocouple. 
Each thermocouple was calibrated within a specific confidence range around its 
working temperature in the mock loop system. A mock loop test calibration guide (Table 
4.8) for the operational ranges for each thermocouple was created to keep track of each 
















Cath Inlet Temp -1.0 – 15 -3, 0, 3, 7, 12, 15, 20 ±0.28 Generated flow 




HX Outlet Temp -1.0 – 15 -3, 0, 3, 7, 12, 15 ,20 ±0.55 
Ambient Temp 15 – 25 12, 15, 20, 23, 25, 30 ±0.38 
Aorta (core) 
Temp 
35 – 40 30, 33, 35, 37, 40 ±0.25 




A linear regression and R2 value was determined for each thermocouple data set 
to validate the accuracy of the calibration. The new slope and intercept value from each 
thermocouple’s linear regression plot was added to the LabVIEW DAQ as a new 
calibration input value. 
The process for calibrating flow meters and pressure transducers was similar to 
the thermocouple calibration method. A total of five calibration points were spread 























Coronary test calibration guide for the operational ranges for each instrument – 
Continued. 





3000 – 4000 
ml/min 






– no recalibration 
necessary 
Coronary 
70 – 200 
ml/min 




Checked with water 
weight of graduated 
cylinder divided by 
time 










50 – 170 
mmHg 
40, 80, 120, 140, 170 
± 1.46 
mmHg 





After the data was recorded using LabVIEW, it was plotted in Excel and a new 
slope was determined. A linear trend line was added to each graph, as well as the R2 
value. An R2 value greater than 0.98 was considered satisfactory for the turbine flow 
meter and pressure sensor calibrations. Coronary and aorta flow were calibrated with an 
accuracy of ± 1.04 ml/min and ± 27 ml/min, respectively. The Aorta flow meter was 
within the ± 200 ml/min acceptable limit for the calibration, therefore, no recalibration 
was needed. The inputs, control variables, and outputs employed in the calibration 





































Figure 4.6. Snapshot of the calibration design of experiments for thermocouple, flow, and 








-1 - 15 (℃) 
15 - 25 (℃) 
35 - 40 (℃) 
-1 - 15 (℃) 
6 - 30 (℃) 
N = 7 
N = 6 
N = 5 
N = 7 











3000 - 4000 (ml/min) 
70 – 200 (ml/min) 
N = 5 
N = 5 
±200 (ml/min) 
±1.04 (ml/min) 
Parameters Variables Outputs 




0 – 30 psi 
50 – 170 mmHg 
N = 6 
N = 5 
±0.48 psig 
±1.47 mmHg 
Inputs Parameters Variables Outputs 
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To calibrate infusate flow rates, the peristaltic pump in the cooling console varied 
flow between 10 and 90 ml/min which was collected and measured in a graduated 






Calibrated infusate flowrates exiting the guide extension from peristaltic pump in the 
cooling console. 
Description Value Units 
Pump Flow Rate 10 20 30 50 70 90 
Calibrated Flowrate 9.08 19.3 29.20 49.0 68.8 88.9 ml/min 




The catheter inlet pressure and distilled water flow rates were measured using a 
pressure transducer (PendoTech, Princeton, NJ) and a turbine flow meter (McMillan, 
Georgetown, TX), respectively. The temperature and flow rate of the catheter was 
monitored and controlled by the user with a computer running LABVIEW (National 
Instruments Co., Austin, TX). 
Medical devices. The medical devices used in this study (Table 4.11) comprised 
of a 7F Cordis® guide and a 7F guide extension that was advanced through the guide to 




Make and model for each medical device used in the mock loop system. 
Device Model Description 
7F Guiding Catheter Cordis Vista BriteTip® (Part Number: JL 3.5) 




Results of In Vitro Studies 
 
 In this section we present the temperatures and flow rates at the guide inlet and 
guide extension outlet, as well as the cooling capacity of the Cordis® guide for all 
temperatures and flow rates used in the mock loop system. The term, infusate flow, will 
be referred to in this section as the flow being pumped from the cooling console and 
exiting the tip of the guide extension.  
Temperatures. Aorta (core) temperatures were held constant at 37.07⁰ C ± 0.046 
for all the mock loop trials. The Calibrated Infusate flow rates ranged between 9.08 and 
88.9 ml/min (Table 4.12), and the temperatures for the heat exchanger outlet, catheter 





Various temperatures recorded from infusate flow rates ranging from 9.08 ml/min to 88.9 
ml/min in the cooling console circuit.  
Description Units Value 
Calibrated Infusate 
Flow Rates 
ml/min 9.08 19.27 29.2 49.03 68.85 88.9 
Heat Exchanger 
Outlet Temp 
⁰C 1.83 1.34 1.1 0.92 0.91 0.83 
Catheter Inlet 
Temperature 
⁰C 8.205 4.78 3.52 2.46 2.087 1.76 
Guide Extension 
Outlet Temperature 




As seen in Table 4.8, infusate flows in the cooling console circuit retained cooler 
temperatures with higher flowrates. To visualize this scene, temperatures entering the 
Cordis® guide and exiting the guide extension tip were plotted (Fig. 4.7) against their 






Figure 4.7. Temperatures entering the Cordis® guide and exiting the guide extension vs 
infusate flow rates from mock loop cooling console. Increased infusate flowrates resulted 
in lower fluid temperatures both entering and exiting the Cordis® guide and guide 
extension, respectively. Infusate flowrates leaving the heat exchanger varied between 




Flows. The cooling console circulated distilled water from a small reservoir into 
the heat exchanger and was expelled as chilled fluid <1⁰ C before entering the guide. 
Flow rates entering the Cordis® guide ranged between 9.08 and 88.9 ml/min (Table 4.13) 





Standard deviation (SD) for flow rates, guide extension inlet temperature, and guide 
extension outlet temperature. 
Infusate Flow (ml/min) Guide Inlet (⁰C) Guide Extension Outlet (⁰C) 
Flowrate SD Temperature SD Temperature SD 
9.08 0.0289 8.205 0.0414 36.31 0.0521 
19.27 0.1041 4.478 0.0555 33.36 0.3203 
29.2 0.0866 3.52 0.0429 29.4 0.1881 
49.03 0.2309 2.459 0.0321 23.16 0.1564 
68.85 0.2179 2.087 0.0141 19.2 0.0944 



























Catheter inlet temperatures ranged between 1.76⁰ C and 8.205⁰ C with a standard 
deviation ranging between 0.0141⁰ C and 0.0555⁰ C for all six inlet temperatures. The 
temperatures exiting the guide extension ranged between 16.36⁰ C and 36.31⁰ C with a 
standard deviation between 0.0944⁰ C and 0.3203⁰ C for all six guide extension outlet 
temperatures.  
Cooling capacity. Cooling capacity, ?̇?𝐼, was calculated using data obtained from 
the chilled infusate catheter flow rates and guide extension outlet temperatures using 
equation 4.1:  
?̇?𝐼 = ?̇?𝐼𝑐𝑝∆𝑇𝐼                    (4.1) 
where ?̇?𝐼 is the heat capacity of the infusate in watts, ?̇?𝐼  is the mass flow rate of the 
chilled infusate in kg s−1, 𝑐𝑝  represents the specific heat of the chilled infusate in J 
kg−1C−1, and ∆𝑇𝐼 represents the delta between the mock loop core temperature and the 
guide extension outlet temperature in ℃. The characteristic values for ?̇?𝐼, 𝑐𝑝 and ∆𝑇𝐼 
were 1.513e-4 – 1.482e-3 kg s−1, 4186 J kg−1C−1, and 0.72 – 20.7 ℃, respectively. The 




Data obtained for the infusate flow rates, guide extension outlet temperatures, and aorta 
temperatures using Eq. 4.1 to solve for cooling capacity. 





Aorta (⁰C) Delta (⁰C) Cooling 
Capacity (W) 
1 9.08 ± 0.029 36.31 ± 0.052 37.028 ± 0.049 0.72 ± 0.10 0.45 ± 0.06 
2 19.27 ± 0.104 33.36 ± 0.320 37.023 ± 0.078 3.67 ± 0.24 4.93 ± 0.31 
3 29.2 ± 0.087 29.40 ± 0.188 37.116 ± 0.070 7.72 ± 0.18 15.72 ± 0.41 
4 49.03 ± 0.231 23.16 ± 0.156 37.068 ± 0.053 13.91 ± 0.12 47.58 ± 0.57 
5 68.85 ± 0.218 19.20 ± 0.094 37.033 ± 0.080 17.83 ± 0.01 85.65 ± 0.34 
6 88.9 ± 0.360 16.36 ± 0.125 37.061 ± 0.068 20.7 ± 0.06 128.41 ± 0.41 





 It is worth noting from Table 4.10 that infusate flow in line 1 is approximately 
one-tenth the value of the infusate flow in line 6, whereas corresponding cooling 
capacities (Eq. 4.1) do not reflect this same ratio. Specific heat, 𝑐𝑝, in Eq. 4.1 is constant, 
thus cooling capacity must be contingent upon either mass flowrate, ?̇?𝐼, or the change in 
fluid temperature, ∆𝑇𝐼. Since fluid temperature in line 6 is two orders of magnitude 
greater than line 1, then the resultant cooling capacity ratios become significantly 
dependent on the ∆𝑇𝐼 along the catheter rather than infusate flow, which varies only by 
one order of magnitude. 
By applying the data obtained for infusate flow and guide extension outlet 
temperatures in Table 4.11, a plot can be generated (Fig. 4.8) to show cooling capacity as 





Figure 4.8. Cordis® 7F guide cooling capacity for flowrate vs outlet temperature. Blue 
circles represent the power (W) required to produce guide extension outlet temperatures 
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Summary and Connection to Computational Work 
In summary, the distilled water exiting the guide extension resulted in 
temperatures between 36.31⁰ C and 13.36⁰ C and volumetric flowrates ranging between 
9.08 ml/min and 88.9 ml/min, respectively.  
The minimum power required to cool infusate fluid to TH temperatures required a 
minimum of 15.72 Watts, which yielded an outlet temperture of 29.4⁰ C. Although six 
flowrates were analyed and tested in the mock loop system, only three were chosen for 
the CFD simulations. The first three flowrates that exhibited TH temperatures were 
chosen for the CFD simulations; 29.2 ml/min, 49.03 ml/min, and 68.85 ml/min.  
The outlet temperatures and flow rates attained from this study were used as the 
guide extension outlet conditions in the CFD modeling studies for all representative heart 
(RH) models. The vascular differences between these RH models are discussed in detail 















Representative Hearts (RH’s) 
Source of Human Heart 3D Models 
 In 1997, the Visible Heart® Project was launched as a subsidiary medical division 
to the University of Minnesota. In 2000, the free-access website, Atlas of Human Cardiac 
Anatomy was launched from Visible Heart® to provide free images, videos, and CT/MRI 
DICOM files to students, academia, and industry personnel [135]. As of 2016, Visible 
Heart® has reanimated 75 human hearts and its Atlas website contains human cardiac 
anatomy images from more than 400 human heart specimens. With permission from a 
donor’s family, LifeSource, a non-profit organ donation company, donates hearts from 
organ donors that have been considered non-viable for transplantation to the Visible 
Heart® Laboratory (VHL) [135]. Computed tomography (CT) and magnetic resonance 
(MR) imaging of the donated hearts are performed internally and uploaded in DICOM 
format to the Atlas website.  
Each human heart (HH) is numbered on the Atlas website and contains detailed 
descriptions for each specimen’s gender, age, and cardiac medical history. VHL was an 
excellent resource for attaining our high quality cardiac images that can also be used to 
help guide the verification and development process of new therapeutic hypothermia 
(TH) transcatheter therapies.  
Rationale for selecting specific RH’s 
 
The complex structure of cardiac anatomy plays a vital role in cardiac medical 
device design and procedures [136][137]. Understanding anatomical variations in human 
hearts is a critical factor for determining its impact on cardiovascular interventions 
[138][139][140]. To better understand anatomical variations in left main coronary artery 
(LMCA) networks and their impact on cardiovascular procedures, a collection of HH 
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models were strategically selected for this study to represent a unique set of similar 
patient-specific LMCA networks.  
The rationale for choosing similar heart models was to apply “identical” CFD 
boundary conditions and physics solvers to analyze the impact of each patient’s coronary 
structural variations on heart cooling. Human hearts in the VHL database that expressed 
similarities in LMCA anatomical networks were chosen for this work. The similarities 
between each model were identified visually based on their vascular network and 
included similarities in artery network patterns, vessel diameters, and vessel lengths. 
Choosing hearts with large proximal left anterior descending (LAD) and left circumflex 
(LCX) artery diameters was critical for accommodating the insertion of a GuideLiner® 





Figure 5.1. Proximal LAD and LCX GuideLiner® insertion method. Large proximal 




For this study, we analyzed 33 patient-specific human hearts from the VHL 
database. After careful consideration, we chose six human hearts that have no 
abnormalities and most closely resemble normal LMCA geometries and anatomical 
configurations. Each heart model (Fig. 5.2) contains varying branch lengths, vessel 
diameters, and quantity of bifurcated branches in its network.  








Figure 5.2. Representative hearts (RH) that were chosen for this work. These RH’s were 
created in Mimics® and were exported into STAR-CCM+ for CFD modeling. All RH 



















 Heart Model Structural Comparison 
Each heart model expressed vascular differences that varied in artery lengths, 
diameters, and the number and location of bifurcations stemming from each artery 
segment. Although 6 patient-specific hearts were chosen for this study, no two hearts 
were anatomically identical.  
 Quantify differences between models. The aim of this section is to interpret the 
vascular differences between all heart models and quantify these differences in terms of 
length, area, and surface area to volume ratios. The goal is to link these quantitative 
characteristics to temperature distribution data for each heart model so that assumptions 
can be made regarding the impact of heart structure on cooling effectiveness.   
Lengths. The proximal LAD and LCX is defined as the distance from its left main 
bifurcation to the first major septal perforator [136][137][138][139][140], and the 
distance from its left main bifurcation to the first obtuse marginal branch [6][8], 
respectively.  
The segment lengths of the LAD and LCX arteries varied with each HH model. 
The length and average diameter for each proximal LAD and LCX model was measured 














HH55 mm 19.8 3.14 12.9 2.79 
HH88 mm 31.7 4.12 12.4 3.55 
HH97 mm 15 3.55 9.23 2.78 
HH102 mm 12 2.91 28 2.44 
HH178 mm 22.5 3.03 57.5 2.72 
HH259 mm 25 3.08 29 3.45 
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As seen in Table 5.1, HH102 had the shortest proximal LAD segment (12mm), 
while HH88 had the longest proximal segment (31.7mm). Consequently, HH97 had the 
shortest proximal LCX (9.23mm) and HH178 had the longest proximal LCX (57.5mm). 
From these observations, LAD and LCX artery geometries and their anatomical network 
structures are independent of each other (Fig. 5.3) and will need to be evaluated as 




HH55 HH88 HH97 
 
HH102 HH178 HH259 
 
Figure 5.3. The proximal segments of the LAD and LCX arteries highlighted in yellow. 




A comparison between the first obtuse marginal branches of the LCX for HH88, 













Figure 5.4. Variations in proximal LCX artery lengths. The proximal LCX extends from 
the left main bifurcation to the first obtuse marginal branch (FOM). HH88 (a) contains 
the shortest proximal segment length, while HH259 (b) and HH178 (c) contain the 





As described in Fig. 5.4, HH259’s proximal trunk is 124% longer than HH88’s, 
while HH178’s proximal trunk is 363% longer than HH88. This further supports the 
claim that no two patient-specific heart structures are alike, and that the total lengths of 
each artery network (Table 5.2) will need to be considered for evaluating TH temperature 





Total length of all vessels in each LAD and LCX structure.  
Heart Model Units 
Total LAD Vessel 
Lengths 
Total LCX Vessel 
Lengths 
HH55 mm 433.03 465.5 
HH88 mm 297.7 316 
HH97 mm 372.9 269.03 
HH102 mm 157 286 
HH178 mm 394.3 359.13 
HH259 mm 429.7 373.1 
 
12.4mm 
FOM   
29mm 







Areas. The surface areas for each heart model were generated in SolidWorks 
using the Mass Properties function. Surface areas are listed for each patient-specific LAD 





Overall surface area for each HH model. 
Human Heart (HH) Units LAD Surface Area LCX Surface Area 
HH55 mm2 2404.87 4105.07 
HH88 mm2 2177.65 1752.51 
HH97 mm2 1913.46 1590.99 
HH102 mm2 1030.87 1613.86 
HH178 mm2 2377.44 1937.45 




The smallest LAD artery surface area was HH102. HH55’s LAD and LCX 
arteries both dominated in surface area compared to the rest of the heart models, resulting 
in 2404.87 mm2 and 4105.07 mm2, respectively. The surface area for each LAD and LCX 
heart model was described by a quantitative plot (Fig 5.5) so that a comparison between 






Figure 5.5. Quantitative plot showing the comparison between surface area and all LAD 




Volumes. Like the surface area comparison in Fig. 5.5, a volume comparison 
between all LAD and LCX RH models were plotted together (Fig. 5.6) so that a 





Figure 5.6. Quantitative plot showing the comparison between volume and all LAD and 












































 Surface area to volume ratios. The surface area to volume ratios for the LAD and 
LCX models compare the size of each artery’s surface area to the volume inside each 
artery’s network. Surface area to volume ratios (SA:V) were calculated for all LAD and 





Surface Area to Volume ratios for each LAD and LCX model employed in the study. 
 HH55 HH88 HH97 HH102 HH178 HH259 Units 
LAD 2.368528 1.727352 2.35666 2.53667 2.747695 2.767548 m-1 




The surface area and volume of each representative heart model was calculated 
using the Mass Properties tool in SolidWorks®. The accuracy of each SA:V ratio could 
be impacted by the guide extension insertion depth in each proximal artery, which ranges 
from 3-5mm. However, SA:V ratio accuracy could be improved if higher resolution 
DICOM images were created in Mimics. This would allow us to locate more bifurcations 
and extend each vessel down to the capillaries (or as close as possible).  
High SA:V ratios are typically a result of low volume objects that exhibit large 
surface areas [141], which could indicate long, thin artery networks in our HH models 












Suppose the volume (amount of space) inside an artery network were to grow. 
The surface area surrounding the volume of this artery network would increase as well 
[142]. Surface area to volume (SA:V) ratios in cylinders can be simplified 
mathematically to 2/R, where R is the radius of the cylinder. Therefore, when volume 
increases, the SA:V ratio decreases, and vice versa.  
Fig. 5.6 shows a visual representation for each heart model and its corresponding 
surface area to volume ratio. HH259 has almost identical surface area values for both its 
LAD and LCX arteries, however, since its LAD has a slightly lower volume to that of its 
LCX, the surface area to volume ratio is larger for its LAD network. This suggests the 
possibility that the LAD for HH259 has smaller and longer vessels than its LCX 
counterpart network.     
 The rationale for choosing the RH models in this study was to execute identical 


































impact of vascular structure on cooling impact. Human heart artery lengths, diameters, 






Thermal Fluid Model Setup for RHs 
Now that we have established the biophysics background (Ch. 2), described the 
computational methods (Ch. 3), and introduced the representative heart models (Ch. 5), 
we will now describe the steps required to solve thermal fluid flow through each of the 
left main coronary artery (LMCA) networks. 
Geometries 
Patient-specific left main coronary artery (LMCA) geometries impact medical 
device performance. We characterized each artery’s network by identifying four main 
branches in the left anterior descending (LAD) artery, and three main branches in the left 





Figure 6.1. Ideal LAD (a) and LCX (b) networks [143]. Note for the LAD (a): first 
diagonal branch (1DB), second diagonal branch (2DB), septal branches (SB), and 
anterior descending (AD). Note for the LCX: first obtuse marginal branch (1om), second 













We identified four main branches that characterized each LAD model [143]; first 
diagonal branch, second diagonal branch, septal branches, and the anterior descending 
branch. Similarly, we identified three main branches that characterized each LCX model 
[143]; first obtuse marginal and second obtuse marginal branches, and the posterolateral 
branch. Lastly, it was important to understand the geometry of the 7F Cordis® guide 
catheter and GuideLiner® used in the in vitro mock loop system. The OD and ID of the 
GuideLiner® tip (Fig. 6.2) was implemented as a modeling parameter in the proximal 





Figure 6.2. Isometric view of a general representation of the OD and ID of the 
GuideLiner® in a straight tube describing the GuideLiner® boundaries for each proximal 
artery. The depth of the insertion varied between 3-5mm and the OD and ID were fixed at 




Physiological geometry. Each of the six heart models that were chosen for this 
study were broken down into the LAD and LCX artery networks. The LAD (Figure 6.3) 
and LCX (Figure 6.4) networks of each patient-specific heart were grouped together so 












Figure 6.3. Patient-specific LAD networks for HH55, HH88, HH97, HH102, HH178, and 
HH259, for hearts a. through f., respectively. Note: first diagonal branch = 1DB, second 
diagonal branch = 2DB, septal branches = SB, and the anterior descending branch = AD. 
HH88 had no identifiable septal perforator branch (b), which could have been attributed 






c. b. a. 




















Figure 6.4. Patient-specific LCX networks for HH55 (a), HH88 (b), HH97 (c), HH102 
(d), HH178 (e), and HH259 (f). Note: the first obtuse marginal branch = 1om, second 
obtuse marginal = 2om, and the posterolateral branch = Plb. HH97 appears to have a third 
obtuse marginal branch (c) that extends between the second obtuse marginal and the 



























It is important to acknowledge that not all vascular features can be easily 
resolved.  Heart model HH88 LAD had no identifiable septal perforator branch, which 
could be a result of 1) poor DICOM image quality that was not able to recognize the 
bifurcation during Mimics® segmentation, or 2) VHL’s CT angiogram imaging method 
did not fully capture the septal perforator branch in the DICOM file. The remaining HH 
models had identifiable branches that enabled us to characterize the anatomical 
differences between each model.   
Medical device geometry. Both the 7F guiding catheter and the 7F GuideLiner® 
were used in the mock loop system. To insert these devices into the circulatory mock 
loop system (Ch. 4), a guide wire was inserted into the proximal hub of the mock loop’s 
femoral artery and advanced through the aorta, where it was steered and exited the left 
main coronary artery (LMCA). Next, the guide catheter was inserted over the guide wire 
and advanced to the ostia of the LMCA. The guide catheter was fixed at the LMCA 
ostium and a GuideLiner® was inserted through the guide catheter and advanced 8.5cm 
out of the catheter outlet. 
Although both devices were used in the mock loop study, only 3-5mm of the 
GuideLiner® tip was modeled and used in the CFD simulations. A description and list of 





Descriptive parameters for each medical device used in the mock loop system. 
Device Location Value Device Length 
7F Guiding Catheter (0.078” 
ID) 
ID 1.98mm 100cm long 
OD 2.3mm 




 As seen in Table 6.1, the GuideLiner® is 50% longer than the guide catheter so 
that it can be inserted and advanced out of the guide catheter. Clearance between the 
GuideLiner® OD wall and the guide catheter ID wall was 0.08mm.  
To make the inlet geometry as reasonable as possible, we chose to implement an 
eccentric inlet geometry for each HH model. Since eccentric GuideLiner® placements 
were evident in the mock circulatory loop (Ch. 4), we can assume that the same 
phenomenon holds true in a clinical setting. Therefore, to retain consistency, an eccentric 
GuideLiner® insertion was assumed lining the anterior side of the coronary artery for all 
CFD simulations. A general representation for the GuideLiner® inlet geometry in the 





Figure 6.5. Sagittal view of a general representation of the inlet geometry and boundaries 
describing the GuideLiner® placed in each proximal LMCA. The depth of the insertion 





 It would be unreasonable to assume that physicians achieve consistent eccentric 
placement of the GuideLiner® in each proximal LAD and LCX artery in a clinical 
setting. If however, perfect concentricity could be achieved during intracoronary 








1.90 mm OD 1.57 mm ID 
3-5 mm Insertion LMCA ID 
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to the arterial cross-section, then temperature distribution results would undeniably be 
changed. Therefore, to retain consistency in our CFD simulations, an eccentric 
GuideLiner® insertion lining the anterior side of the artery was assumed for all CFD 
cases. 
Physics  
Prior to executing a CFD model, physics conditions need to be determined so that 
STAR-CCM+, the finite volume method solver, can apply the correct governing 
equations. Table 6.2 describes a list of parameters used for the physics conditions in each 
of our CFD models.  
 
Table 6.2 
Physics conditions used for each CFD heart model in STAR-CCM+. 
Parameter Value Description 
Space Three Dimensional x, y, and z coordinate space 
Time Steady T = constant. Results 
represent a single point in 
time. 
Material Liquid --- 
Flow Segregated Flow Continuity, momentum, and 
energy are solved 
sequentially (segregated from 
each other). 
Equation of State Constant Density Incompressible fluid 
Viscous Regime Laminar Re < 2300 
Solver Segregated Fluid Temperature Entire energy equation is 
solved with T as independent 
variable. Enthalpy is then 
calculated from temperature 
as stated by the equation of 
state. 






Governing equations. As discussed in Chapter 2, the Navier-Stokes equations for 
conservation of linear momentum (Eq. 2.4a), the continuity equation of conservation of 
mass (Eq. 2.5), and the conservation of thermal energy (Eq. 2.7), govern the fluid 




 =  𝜌𝑔 −  𝛻𝑝 +  𝜇 · 𝛻2𝑉                     (2.4a) 










] = 𝑘 [
𝜕2𝑇
𝜕𝑥2
] + 𝑘 [
𝜕2𝑇
𝜕𝑦2
] + 𝑘 [
𝜕2𝑇
𝜕𝑧2
]                     (2.7) 
where Eq. 2.7 is coupled with Eq. 2.4a because the viscosity, 𝜇(𝑇) is a function of 
temperature, where T is determined from Eq. 2.7. The coupling is performed so that 
viscosity can be solved as a function of temperature, 𝜇(𝑇). 
Boundary conditions. Equations 2.4a and 2.5 are applied as the governing 
equations necessary to solve fluid pressure and velocity fields in the coronary arteries. To 
solve these equations for flow field properties, appropriate boundary conditions will need 
to be fixed. The boundary conditions implemented in each heart simulation are described 







Figure 6.6. HH55 LAD Navier Stokes and thermal energy boundary conditions applied to 
all patient-specific RH models. Identical boundary conditions were applied to each of the 
remaining LAD and LCX artery models. Each heart model exhibits a single blood flow 
inlet and GuideLiner® flow inlet. The number of outlets for each heart model varied and 
ranged from 7 outlets for HH88 LAD to 33 outlets for HH55 LCX. Navier-Stokes 
description is designated to left of comment (slash), while thermal energy is represented 




For this study, six patient-specific hearts were chosen and prepared for CFD 
modeling. The LMCA for each heart was modeled and segmented into six LADs and six 
LCXs. Each of the 12 patient-specific heart models represent the blood domain of the 
LAD and LCX and excludes the vascular wall and tissue domain. Each heart model 
represents patient-specific asymmetric artery networks with rigid, no-slip boundary 
conditions at the walls, where velocity is zero.  
The outlets were assumed to a constant pressure of 0.0 pascal.  The inlets used a 
mass flow inlet condition that represented both the blood flow and chilled GuideLiner® 
Outlets Continued 




Inlet: Blood Flow / 𝑇𝑖𝑛 
Inlet: GuideLiner® Flow / 𝑇𝑖𝑛 
No-Slip / Isothermal Walls 
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flow entering the artery. Although blood flow is pulsatile in nature and GuideLiner® 
flow is steady, a steady state laminar blood and GuideLiner® flow rate was assumed. 
Blood will be considered as an incompressible, Newtonian fluid, as described in Chapter 
2. Dynamic viscosity and its shear-thinning correlation will be discussed in greater detail 
later in this chapter. 
To simulate therapeutic hypothermia (TH) in the blood domain, a catheter is 
typically inserted into the femoral artery and advanced into the coronary ostia. A 
GuideLiner® is advanced out of the catheter and into the proximal artery (Fig. 6.7) where 





Figure 6.7. Eccentric GuideLiner® catheter in the proximal HH55 LAD representing two 
distinct inlets for the GuideLiner® and blood flow. Inlet flow conditions for the blood 




In vivo blood flow rates entering the proximal LAD and LCX arteries have been 
determined using methods involving lumped parameter modeling of computed 
tomography (CT) scans [9], 3-dimensional epicardium simulations [10], ultrasound [11], 
and phase contrast magnetic resonance imaging (MRI) [12]. As a result, average blood 
78 
 
flow in the LMCA is estimated between 29.06 mL/min and 90.6 mL/min [9][12]. Thus, 
based on these findings, we chose a distinctive total inlet flow rate of 75 mL/min (Fig. 





Figure 6.8. Average left coronary artery blood flow as determined in literature using 
various methods involving lumped parameter modeling, 3D epicardium simulations, 
ultrasound, and phase contrast MRI. Based on these published findings, a total inlet flow 




Where the total inlet flow rate of 75 mL/min is independent of blood and 
GuideLiner® flow rates (Fig. 6.9), and remain a constant parameter for all CFD 
simulations. 
 
Figure 6.9. Total inlet flow rate representing GuideLiner® and blood flow entering each 





Bao, 2018 (CT & LPM) 
Kim, 2010 (3D Epicardium Sim.) 
Wieneke, 2004 (Ultrasound) 
Johnson, 2008 (PC-MRI) 
Thesis Work (75 mL/min) 





Boundary conditions are an important pre-processing step to solving any CFD 
model. Once boundary conditions are fixed, they govern the domain and boundaries of 
the model and set the stage for executing the CFD solvers. Table 6.3 lists detailed 





Boundary conditions and equations applied to each human heart model in STAR-CCM+. 
The inlet conditions represent the final three flow rates used in the CFD simulations. 
Boundary Condition Navier-Stokes Thermal Energy References 
Blood In 6.15 ml/min - 
45.8 ml/min 
37°C [4], See Chapter 
4 – Results 
GuideLiner® In 29.2 ml/min - 
68.85 ml/min 
29.4°C – 19.2°C See Chapter 4 - 
Results 








We assume that the rate of change of temperature along the vessels approaches 
zero at the vascular outlets, therefore 
𝛿𝑇
𝛿𝑠
= 0. As the purpose of this study is to examine 
temperature distributions in patient-specific LAD and LCX arteries, setting the wall 
temperature to isothermal is an expedient assumption for this study. The expectation of 
impending tissue cooling studies is that wall-coupled heat transfer exists in real life 
applications and should be implemented in future studies to improve model fidelity.  
Properties 
We used mixture properties of blood and distilled water (infusate), after the two 





Figure 6.10. Theoretical description of how mixture properties for blood and distilled 
water were determined for the CFD inlet boundary conditions. 𝑇 = 𝑎, 𝑏, 𝑐 represents the 
guide extension inlet temperatures 29.4, 23.16, and 19.2°C with corresponding flow rates 
29.2, 49.03, 68.85 ml/min, respectively. Blood and distilled water was mixed at 𝑇 =
𝑎, 𝑏, 𝑐 guide extension infusate temperatures, and new mixed blood and infusate 




The blood and distilled water flow through the guide extension entering the 
proximal end of the artery represents a mixture of the two. However, although both fluids 
have the same properties after mixing, the mixed infusate fluid will be entering the guide 
extension inlet at temperatures (a, b, c) (Fig. 6.10), while the mixed blood fluid will be 
entering the blood flow inlet at 37°C. Since we assume complete mixing happens 
immediately beyond the inlet, a limitation to this approach will be that the properties 
down-stream are not experiencing perfect mixing. This will be discussed further in 
Chapter 7.  The three GuideLiner® flowrates and corresponding temperatures used in the 
CFD simulations were determined from Chapter 4 – In Vitro Methods. 
Density. To determine the final mixture property for density after the two fluids 




(?̇?𝐼𝜌𝐼 + ?̇?𝐵𝜌𝐵)     (6.1) 
HH102 LCX 
Mixing Chamber 
Blood (𝑇 = 37℃) 
Distilled  
Water 
(𝑇 = 𝑎, 𝑏, 𝑐) 
Heating Chamber 
(𝑇 = 37℃) 
Cooling Chamber 
(𝑇 = 𝑎, 𝑏, 𝑐) 





where 𝜌𝑚 is the mixed density (
𝑘𝑔
𝑚3
), ?̇?𝐼 is the infusate mass flow rate (
𝑘𝑔
𝑠
), ?̇?𝑇 is the 
total mass blood flow (
𝑘𝑔
𝑠
) into the artery, ?̇?𝐵 is the blood mass flow rate (
𝑘𝑔
𝑠
), and 𝜌𝐼 
and 𝜌𝐵 are the infusate and blood density (
𝑘𝑔
𝑚3
), respectively.  
Thermal conductivity. To determine the mixture thermal conductivity after the 




(?̇?𝐼𝑘𝐼 + ?̇?𝐵𝑘𝐵)     (6.2) 
where 𝑘𝑚 is the mixed thermal conductivity (
𝑊
𝑚⋅𝐾
), and 𝑘𝐼 and 𝑘𝐵 is the thermal 
conductivity of the infusate and blood (
𝑊
𝑚⋅𝐾
), respectively.  
Specific heat. To determine the mixture specific heat after the two fluids mixed, 
Eq. 6.3 was used: 
        𝑐𝑝,𝑚 =
1
?̇?𝑇
(?̇?𝐼𝑐𝑝,𝐼 + ?̇?𝐵𝑐𝑝,𝐵)     (6.3) 
where 𝑐𝑝,𝑚 is the mixed specific heat (
𝐽
𝑘𝑔⋅𝐾
), 𝑐𝑝,𝐼 and 𝑐𝑝,𝐵 is the specific heat of the 
infusate and blood (
𝐽
𝑘𝑔⋅𝐾
), respectively.  
 To determine the final mixture property for the temperature after the two fluids 
mixed, the temperature and specific heat for both fluids, as well as all three flowrates 




     (6.4) 
where 𝑇𝑚 is the mixed temperature(℃), and 𝑇𝐼 and 𝑇𝐵 is the temperature of the infusate 
and blood(℃), respectively. The mixed temperature 𝑇𝑚 is used as a parameter to solve 
for the dynamic viscosity. 
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 Dynamic viscosity. To determine the dynamic viscosity, Eq. 2.11 from Chapter 2 
was used to determine the dynamic viscosity as a function of mixed temperature 𝑇𝑚 (℃), 
shear rate Υ (
1
𝑠
), and hematocrit (Hct (%)) for each infusate flow rate [123].  





]     (2.11) 
Therefore, the shear rate, hematocrit, and temperature are independent variables 
and the dynamic viscosity is the dependent variable for this solution. Please see Appendix 
B for a description of how viscosity is entered as a function of temperature in STAR-
CCM+. 
Property summary. Key properties are density (𝜌), specific heat (𝑐𝑝), thermal 
conductivity (k), and dynamic viscosity (µ), as shown in the governing equations (Eq. 
2.11 and Eq. 6.1 to 6.4). The material properties for both blood and distilled water are 





Material properties for blood and distilled water entering the proximal LAD and LCX 
[146][147][148]. 
Material Property Units Blood Distilled Water 
Density (𝝆) kg/m3 1060 1006 
Specific Heat (𝒄𝒑) J/kg-K 3560 4180 
Thermal Conductivity (k) W/m-K 0.52 
(at 37℃) 
0.598 to 0.614 




Blood properties were determined from literature [130][140] assuming whole 
blood, meaning plasma plus red blood cells at 37℃, while the distilled water properties 
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were determined from the in vitro GuideLiner® infusion temperatures ranging between 
19.2℃ and 29.4℃. 
The blood and GuideLiner® inlet conditions in each CFD model represent blood 
properties from literature combined with the in vitro circulatory loop distilled water 
properties. These two fluids experienced different flow rates and temperatures 
undergoing developing flow in the proximal artery network. Density and specific heat 
were assumed to be dependent on the blood and distilled water material property only, 
rather than temperature, since blood and distilled water were assumed to be mixed having 
combined thermal-fluid properties. Table 6.5 summarizes the mixed material properties 





Blood and distilled water mixed fluid properties at variable GuideLiner® flow rates. 






Density (𝝆) kg/m3 1010.43 1024.7 1038.98 
Specific Heat (𝒄𝒑) J/kg-K 4129.16 3965.31 3801.39 
Thermal Conductivity (k) W/m-K 0.5916 0.5723 0.5566 
Dynamic Viscosity (μ) Pa-s 0.00358 0.00205 0.00180 
Shear Rate (𝜰) 1/s 2060.66 
Mixed Temperature (T) ℃ 20.4584 27.4625 33.7464 
Note. Mixed fluids 1, 2, and 3, correspond to GuideLiner® flow rates 68.85 ml/min, 




The material properties employed in the CFD model, specifically density, specific 
heat and thermal conductivity, were calculated as a mixture assuming perfect mixing of 
the blood and distilled water. The resulting mixed fluid properties were established as the 




Dynamic viscosity is the only property dependent on temperature, hematocrit, and 
shear rate, as seen in Eq. 2.11. The remaining mixed properties such as density (𝜌𝑚), 
specific heat (𝑐𝑝,𝑚), and thermal conductivity (𝑘𝑚) are dependent on flow rate, as seen 
in equations 6.1 to 6.3. Blood and GuideLiner® inlet temperature conditions were 
assumed to be mixed (Fig. 6.10) and employed as inlet conditions for each thermal fluid 
model. Mixed temperature conditions were dependent on specific heat of both fluids, 
blood flow rate, and each of the three GuideLiner® inlet flow rates. The key property 





Key properties and assumptions for each mixed fluid. 
Property Assumption 
Density Temperature independent & flow rate dependent 
Specific Heat Temperature independent & flow rate dependent 
Thermal Conductivity Temperature dependent 
Mixed Temperature Flow rate & specific heat dependent 




 In summary, the in vitro mock circulatory loop contained distilled water only. The 
fluid properties for each corresponding GuideLiner® flow rate were calculated from the 
in vitro mock circulatory loop and the blood plasma properties were determined from 
literature (see Table 6.4). The material properties and corresponding assumptions (Table 
6.6) for the blood and distilled water were combined to determine mixed fluid properties 







Mesh convergence. A mesh convergence analysis, as described in Chapter 3, was 
performed for each of the 6 LAD and 6 LCX models to determine an appropriate mesh 
density. The mesh density was determined by setting various base sizes in STAR-CCM+. 
Base sizes in STAR-CCM+ are values that enable ratios to exist between boundary 
conditions and the physics solvers. If the base size is a large value, the mesh will be 
coarse, and the physics solvers will not compute an accurate solution. On the other hand, 
if the base size is a small value, the mesh will be generated as a fine mesh and will yield a 
more accurate solution, albeit, with greater computational expense. 
For all models, a polyhedral mesh was generated using 3 prism layers (Fig. 6.11), 




        
Figure 6.11. A close-up of the cells that encompass the polyhedral mesh (a) and a close-
up of the 3 prism layers formed at each wall boundary (b). The prism layers are fixed at 





The prism layered mesh at the wall boundaries ensured that physics being solved 




The mesh density and mesh size are discretization parameters that must be 
determined to yield accurate solutions in CFD modeling. The mesh quality in this study 
will be defined by the number of cells in the model. Table 6.7 lists the number of cells 
associated with three arbitrary heart models, as well as the time required to compute each 





Three LAD and LCX models chosen at random and their associated mesh quality and 
computational time using two discrete computing hardware. 
Human Heart Model Base Size 
Mesh Quality 




HH88 (LAD) 0.00015 m 799,705 2.86 min --- 
HH88 (LCX) 0.00015 m 599,609 3.37 min --- 
HH97 (LAD) 0.00015 m 655,940 2.69 min 7.34 min 
HH97 (LCX) 0.00015 m 535,340 3.14 min --- 
HH178 (LAD) 0.00015 m 812,517 4.51 min 8.81 min 
HH178 (LCX) 0.00015 m 677,797 4.22 min --- 
Note. WS1 and WS2 are workstations 1 and 2, respectively, comprising of different 
computer hardware. Details on the specifications of WS1 and WS2 computer hardware 




A mesh convergence study was executed for all artery models using a best 
practice convergence tolerance residual level of 1 x 10-4 [106] for each of the steady state 
physics simulations. All LAD and LCX meshes contained approximately 8x105 cells 
which was sufficient for executing the CFD solvers in the blood domain.  
The mesh for HH97 LAD was executed using WS1 and resulted in a volume 
meshing speed of 2.69 minutes (Table 6.7). In contrast, when the same operation was 
performed using WS2, the volume meshing speed was deferred to 7.34 minutes. WS1 
was generally 2x faster at computing volume meshes compared to WS2, and was used as 
the primary machine to execute all computationally demanding mesh convergence 
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analyses and STAR-CCM+ simulation runs. Table 6.8 illustrates the cell count for each 
of the simulated LAD and LCX models. 
 
Table 6.8. 
Cell count and corresponding work station for each LAD and LCX model executed. 
























LCX 1,251,094 WS2 





The optimum base size of 0.00015m used across all models was determined using 
a mesh convergence analysis executed for the HH178 LAD (Fig. 6.12) and HH88 LCX 










Figure 6.12. A total of six base sizes were chosen for each heart model and the resultant 
number of cells were plotted against the ABT (a) at a cross sectional plane (CSP) (c) in 
the artery network. A proximal mesh view (b) shows the cells lining the surface of the 
HH178 LAD model. A base size of 0.00015 m resulted in a reasonable number of cells 
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Figure 6.13. Six base sizes were chosen for heart HH88 LCX and the resultant number of 
cells were plotted against the ABT (a) at a cross sectional plane (CSP) (b). A proximal 
mesh view (b) shows the cells lining the surface of the HH88 LCX model. A base size of 




 The red triangle in Figs. 6.12a and 6.13a present a reasonable base size (1.5e-4 m) 
to be used for determining accurate ABT’s for all the models balancing solution accuracy 
vs computational cost. Optimal mesh size was chosen based on temperatures that were 
measurable and clinically relevant in the real world. In this case, thermocouples 
measuring GuideLiner® outlet temperatures (Table 4.6 in chapter 4) were calibrated to an 
accuracy of ±0.36°C. As a result, over half a million cells were reduced using a base size 
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sizes varied within the thermocouples calibrated accuracy of ±0.36°C. The remaining HH 
mesh analysis studies were satisfactory since a tolerance of 0.5℃ was deemed acceptable 
for this study and ABTs remained within ±0.36°C at the GuideLiner® outlet. 
Thermal Fluid Model Testing Matrix 
A thermal fluid modeling matrix was created to explore all six patients. Each of 
the six LAD and LCX heart models required a total inlet flow rate of 75 mL/min (Fig. 
6.9) that was independent of GuideLiner® and blood flow rate (Table 6.3), which 
resulted in 36 total CFD models that needed to be organized and modeled correctly. 
Therefore, the thermal fluid model testing matrix (Table 6.9) was a critical component for 





Thermal fluid model testing matrix used to describe the catheter type, location, inlet 
conditions, and models used in this thesis work. Please see Appendix C for a more 
comprehensive version of the thermal fluid modeling matrix. 




Flow Rate (ml/min) Model # 
Total Blood GuideLiner® 
LAD 75 45.8 29.20 HH55_1 
25.97 49.03 HH55_2 
6.15 68.85 HH55_3 
LCX 75 45.8 29.20 HH55_4 
25.97 49.03 HH55_5 




Flow Rate (ml/min) Model # 
Total Blood GuideLiner® 
LAD 75 45.8 29.20 HH88_1 
25.97 49.03 HH88_2 
6.15 68.85 HH88_3 
LCX 75 45.8 29.20 HH88_4 
25.97 49.03 HH88_5 









Flow Rate (ml/min) Model # 
Total Blood GuideLiner® 
LAD 75 45.8 29.20 HH97_1 
25.97 49.03 HH97_2 
6.15 68.85 HH97_3 
LCX 75 45.8 29.20 HH97_4 
25.97 49.03 HH97_5 




Flow Rate (ml/min) Model # 
Total Blood GuideLiner® 
LAD 75 45.8 29.20 HH102_1 
25.97 49.03 HH102_2 
6.15 68.85 HH102_3 
LCX 75 45.8 29.20 HH102_4 
25.97 49.03 HH102_5 




Flow Rate (ml/min) Model # 
Total Blood GuideLiner® 
LAD 75 45.8 29.20 HH178_1 
25.97 49.03 HH178_2 
6.15 68.85 HH178_3 
LCX 75 45.8 29.20 HH178_4 
25.97 49.03 HH178_5 




Flow Rate (ml/min) Model # 
Total Blood GuideLiner® 
LAD 75 45.8 29.20 HH259_1 
25.97 49.03 HH259_2 
6.15 68.85 HH259_3 
LCX 75 45.8 29.20 HH259_4 
25.97 49.03 HH259_5 




Each of the heart models in the thermal-fluid model testing matrix (Table 6.9) 
were executed in STAR-CCM+ using the methods described in this chapter. The results 
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of each CFD simulation were used to predict the impact of each patient-specific heart 
structure on cooling effectiveness. A rationalization for how cooling effectiveness was 
defined, as well as a parametric study descibing the impact of patient-specific heart 







Thermal Fluid Model Predictions 
 
Overview 
Studies involving the biophysics of heart cooling remain largely unexplored, 
specifically, the biophysics of coronary artery cooling following myocardial infarction. 
Experimental studies have explored myocardial protection techniques using computer 
simulations to examine topical cardiac cooling [101], and conjugate heat transfer by 
pumping cold liquid through the major cardiac chambers [102]. 
Computational vascular research has focused primarily on computing and 
visualizing hemodynamics (i.e. coronary blood shear, pressure, and velocity) 
[4][103][104][105], coronary artery fractional flow reserve (FFR) [106], and lumped 
parameter modeling [75][107]. A lumped parameter model is a mathematical model that 
describes the physiological constraints of a system using parameters that are less 
complex, hence lumped [108]. To our understanding, there is no published literature 
analyzing the biophysics of localized cooling in patient-specific coronary arteries. 
In this study, patient specific left anterior descending (LAD) and left circumflex 
(LCX) artery models are used to explore the impact of vascular geometry on thermal 
fluid behavior in the coronary arteries [13]. A new thermal model is introduced that could 
provide a better understanding of the biophysics of acute myocardial infarction (AMI) 
during TH, as well as provide insight to guide more efficient TH device designs and 
operation parameters [92]. 
The objective of this study is to create thermal fluid models of six patient-specific 
left main coronary arteries (LMCAs). The goal is to predict arterial blood temperatures 
for a variety of hearts and catheter infusion flow rates in the proximal LAD and LCX 
vasculature. The following computational fluid dynamics (CFD) models can help 
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determine and qualitatively analyze temperature distributions in the LMCA’s and can 
help shed light on TH device design and operation to optimize patient outcomes 
following AMI. 
Parametric Study – Sensitivity Analysis 
 Our parametric study will explore three questions: 
1) What is the impact of heart structure on cooling effectiveness? 
2) What is the impact of TH device location placement on cooling effectiveness? 
3) Is there a surface area to volume (SA:V) ratio that reveals cooling 
effectiveness? 
Before these questions can be answered, a basic knowledge of heat transport in 
physiological systems is required.  
Heat transport in physiological systems is a very complicated phenomenon [109]. 
The heart circulates blood flow through vascular systems that reduce in size with each 
branching network until the blood reaches the capillaries. From the capillaries, small 
intravenous vessels are filled with blood which eventually flows into larger vessels that 
bring blood back into the hearts circulation system [109]. Figure 7.1 shows the general 







Figure 7.1. The blood temperature as it navigates through blood vessels of varying 
diameters, as proposed by Chen and Homes [149]. The dashed line indicates the range of 
the tissue temperature surrounding the vessels. Most temperature changes occur in 





 As seen in Fig. 7.1, most of the temperature change occurs in the smaller vessels, 
which contributes to the fact that blood flow temperatures drastically differ from 
surrounding tissue when moderately large vessels experience blood flow. Thus, thermal 
equilibrium between blood vessels and the surrounding tissue is greater in vessels with 
smaller diameters. However, since the scope of this work is limited to the impact of 
cooling in the blood flow paths of coronary artery networks, optimizing the depth of 
cooled blood flow path temperatures in patient-specific models will be the focus of this 
work. 
ABT defined. To accurately measure blood flow in blood vessels and artery 
networks, an average bulk mass flow rate can be calculated to determine the mean flow 
rate at any particular cross-section in the vessel of interest. Therefore, to accurately 
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measure a vessel’s mean temperature distribution at any given cross-section, the average 
bulk temperature (ABT) can be determined.  
The ABT of a fluids cross-section is calculated in STAR-CCM+ using the 




2 ∫ 𝑢𝑇(𝑟, 𝑥)𝑟𝑑𝑟
𝑟𝑜
0
          (2.9) 
where 𝑇𝐴𝐵𝑇 is the average bulk temperature of the fluid, 𝑢𝑚 is the mean velocity, and 𝑟𝑜 is 
the radius of the cross section of interest.  
ABT in patient-specific vascular structures. To determine the ABT for each 
patient-specific heart model, cross-sectional planes were created in STAR-CCM+ that 
started at the artery inlet and extended down each LAD and LCX mother vessel in 5mm 
increments until the planes reached the outlet. The significance of the mother vessel is that 
it comprises of the main fluid domain that carries blood from the LMCA ostia to each of 
the distal LAD and LCX coronary artery trees. A visual representation of the cross-
sectional planes created in the LAD (Fig. 7.2) and LCX (Fig. 7.3) arteries shows the mother 






Figure 7.2. Cross-sectional planes (C-SP’s) spaced 5mm apart extending from HH259 
LAD inlet to the outlet. The mother vessel for each LAD human heart (HH) model 





Figure 7.3. Cross-sectional planes (C-SP’s) spaced 5mm apart extending from HH259 
LCX inlet to the outlet. The mother vessel for each LCX human heart (HH) model 







Mother Vessel Flow Path 





 To determine the impact of coronary vascular structure on cooling effectiveness (CE), 
a basic ratio was created with the intent of being simple and analogous to fractional flow 
reserve (FFR). FFR is a simple calculation used during intracoronary procedures to 
determine the pressure difference across an occlusion [105]. Similar to FFR, CE was 
determined as the ratio of the length of the therapeutic hypothermia average bulk 
temperature (TH-ABT) in the mother vessel over the entire length of the mother vessel 
(Eq. 7.1).  
 
𝐶𝑜𝑜𝑙𝑖𝑛𝑔 𝐸𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒𝑛𝑒𝑠𝑠 (𝐶𝐸) =
𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑓𝑟𝑜𝑚 𝐼𝑛𝑙𝑒𝑡 𝑤ℎ𝑒𝑟𝑒 𝐴𝐵𝑇<35°𝐶 (𝑚𝑚)
𝑇𝑜𝑡𝑎𝑙 𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑀𝑜𝑡ℎ𝑒𝑟 𝑉𝑒𝑠𝑠𝑒𝑙 (𝑚𝑚)
     (7.1) 
 
  We chose ABTs < 35°C for our studies based on Dae et al. 2018, which conducted 
a study analyzing six randomized endovascular cooling trails involving 629 patients [78]. 
As a result, temperatures < 35°C reduced infarct size from 6.5% in control studies to 30%. 
Therefore, ABTs < 35°C were defined as the cut-off temperature for CE. A visual 










Figure 7.4. Cooling effectiveness (CE) represents the ratio of the distance from the 
proximal inlet where TH-ABTs are evident in the mother vessel over the entire length of 
the mother vessel. If TH-ABTs are evident up to and including half the length of the vessel, 
then this vessel would have 50% CE. Furthermore, if TH-ABTs were measured at the 




  The cooling effectiveness calculation (Eq. 7.1) was used as a post-processing 
method and was applied to all CFD simulations comprising of six HH models and 29.20, 
49.03, 68.85 mL/min GuideLiner® flow rates. 
  ABT in single heart with single flow rate. After the cross-sectional planes were 
created in the LAD and LCX arteries for each patient-specific HH model, the thermal fluid 
simulations were executed in STAR-CCM+ using a single flow rate obtained from the in 
vitro mock loop study for each HH patient model. The ABT for each cross-sectional plane 








Figure 7.5. ABT along the LAD mother vessel flow path with single GuideLiner® flow 





Figure 7.6. ABT along the LCX mother vessel flow path with single GuideLiner® flow 
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  As seen in the above figures, a proximal GuideLiner® flow rate of 29.2 mL/min in 
each LAD and LCX for patient HH178 resulted in dissimilar ABTs trends extending along 
the mother vessel. The LAD resulted in an ABT of 34.86°C reaching 45mm into the artery, 
while the LCX resulted in 34.92°C ABT reaching 40mm in the artery. This indicates that 
the anterior descending and left circumflex artery mother vessel flow paths within patients 
have variability in cooling potential outcomes.  
ABT in all hearts with single flow rate. Cross-sectional planes were created along 
the flow path in 5mm increments for each of the six representative heart (RH) models. All 
LAD (Fig. 7.7) and LCX (Fig. 7.8) RH models were executed in STAR-CCM+ using a 
29.4℃ infusate fluid mixture (as described in Chapter 6) at a flow rate of 29.2 ml/min, 
which is similar to a 30 ml/min flow rate used in transcatheter studies to deliver saline in 










Figure 7.7. All LAD representative heart models using a 29.4℃ infusate fluid mixture at a 
flowrate of 29.2 ml/min. Temperature drop in HH88 and HH97, at locations of about 30-





Figure 7.8. All LCX representative heart models using a 29.4℃ infusate fluid mixture at a 
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Since each representative heart (RH) model was infused with an identical 
GuideLiner® flow rate (29.2 mL/min) and temperature (29.4℃) 3-5mm into the proximal 
artery, the results were localized to the 10mm plane (Figs. 7.7 and 7.8) for consistency. 
Figure 7.7 describes the impact of biovariability in the LAD using a single GuideLiner® 
flow rate, which resulted in HH88 experiencing good cooling potential where ABTs <35℃ 
reached 100mm into the mother vessel, as compared to HH259 where ABTs <35℃ reached 
only 40mm into the mother vessel. Similarly, HH88 in the LCX experienced the greatest 
cooling potential while HH55 experienced the poorest, reaching warmer temperatures 
quicker. 
 ABT in single heart with multiple flow rates. The thermal fluid simulation for patient 
HH259 was executed using the three catheter flow rates obtained from the in vitro mock 
loop study; 29.2 ml/min, 49.03 ml/min, and 68.85 ml/min. The ABT for each cross-
sectional plane along the artery’s fluid flow path was plotted for each LAD (Fig. 7.9) and 







Figure 7.9. Results of ABT at each cross-sectional plane location for HH259 LAD using 
flow rates obtained from in vitro mock loop study; 29.2 ml/min, 49.03 ml/min, and 68.85 
ml/min. The rapid spike in ABT at the 40mm plane is the result of a bifurcated septal 
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Figure 7.10. Results of ABT vs cross-sectional plane location for HH259 LCX using flow 
rates obtained from in vitro mock loop study; 29.2 ml/min, 49.03 ml/min, and 68.85 
ml/min. The rapid spike in ABT at the 70mm plane resulted in a bifurcation from the 




As predicted by Chen and Homes [149], most of the temperature change occurred 
in smaller vessels downstream between 3000µm and 1000µm, which suggests that thermal 
equilibrium between the vessel walls and the temperature of the fluid is significantly 
greater in vessels with smaller diameters. Our results indicate that abrupt ABT drops at or 
around 1000µm diameters generally occur between 40-55mm from the catheter inlet, 
which falls within the arterial diameters of Chen and Homes findings [142]. Additionally, 
the ABT in the LAD reached 36.55℃  at 135mm from the artery inlet (Fig. 7.9) using 68.85 
ml/min infusate flow. For the LCX, the ABT resulted in 36.12℃ at 135mm from the inlet 
(Fig. 7.10) using 68.85 ml/min infusate flow. 
Although both ABTs from Figure 7.9 and 7.10 were recorded at 135mm 
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was smaller than the cross-sectional area of the LCX plane (Fig. 7.12), which justifies the 





Figure 7.11. Cross-sectional area of the 135mm cross-sectional plane from HH259 LAD. 
Note: Cross-sectional area: 1.935e-2 mm2. Average bulk temperature (ABT): 36.55℃ at 





Figure 7.12. Cross-sectional area of the 135mm cross-sectional plane from HH259 LCX.  
Note: Cross-sectional area: 1.968e-2 mm2. Average bulk temperature (ABT): 36.12℃ at 






  Cooler temperatures set the foundation for greater cooling rates. The colder the 
GuideLiner® flow is, the more quickly TH-ABTs can reach into the distal arteries. As 
evident in Figures 7.9 and 7.10, GuideLiner® flow rates of 68.85 mL/min most quickly 
cooled and reached the greatest cooling potential along the length of the artery. 
Furthermore, these models do not predict tissue cooling rates, but rather, ABT distributions 
of the coronary artery fluid flow path in each patient-specific HH model. 
  ABT in all hearts with multiple flow rates. The concluding ABT study involved 
analyzing the impact of biovariability on cooling effectiveness across all six patient-
specific heart models using all three GuideLiner® flow rates.  
  In the event of an AMI, clinicians considering localized cooling treatment methods 
should consider the impact of biovariability from patient to patient and the probable 
outcomes that could result using variable GuideLiner® flow rates. To help describe this 
phenomenon, we analyzed the ABTs along each HH model’s mother vessel flow path for 
all hearts using all GuideLiner® flow rates. Final results for the LAD and LCX mother 









































































































































































  The summary of findings herein describe the impact of biovariability between 
patient-specific LMCA vascular structures on proximal GuideLiner® flow rates. Higher 
GuideLiner® flow rates resulted in deeper ABT cooling potential in both the LAD and 
LCX arteries. Although CE varied between patients, GuideLiner® flow rate was the 
dominant factor for reaching TH-ABTs in the distal coronary arteries. Further analysis of 
these findings are described in greater detail later in this chapter. 
ABT dip in HH88 and HH97. A temperature drop was evident in heart HH88 and 
was suspected to be an artifact issue in the STAR-CCM+ physics solvers. The drop 
occurred between the 30 and 35mm planes and dropped in ABT from 34.47℃ to 32.7℃. 
This physical phenomenon could suggest that there was a mysterious thermal energy sink, 
where thermal energy was removed in the blood stream downstream to produce lower 
temperatures in the artery network, which is not physically accurate. According to the first 
law of thermodynamics, energy can neither be created nor destroyed in an isolated system 
[150]. Therefore, further investigation was made to analyze our method for obtaining ABT. 
Both LAD ABT distributions for patient HH88 (Fig. 7.15) and HH97 (Fig. 7.16) consisted 







Figure 7.15. ABT distribution along mother vessel of patient HH88 LAD with artifact issue 
occurring between planes 30mm and 35mm, at 29.2 ml/min. The ABT steadily increases 





Figure 7.16. ABT distribution along flow path of patient HH97 LAD with numerous 
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After much consideration, it was determined that the assumed artifact in Figures 
7.15 and 7.16 were not associated with the inherent approximations of the finite volume 
method, but rather, an issue concerning the stratification of flow. To dive deep in to this 
issue of stratification, rather than creating cross-sectional planes only along the mother 
vessel, we created a continuation of planes in 5mm increments along each bifurcated 





Figure 7.17. Continuation of planes in 5mm increments along each bifurcated branch that 




ABT cross-sectional planes extended from the proximal LAD inlet and spread into 
each bifurcated artery in 5mm increments. Each individual ABT plane that extended down 
the artery network was grouped with the ABT plane that extended an equal distance from 










to determine a final ABT that resembled a stratified fluid mixture 35mm from the artery 
inlet. The summation of planes was determined using the following equation: 
𝐴𝐵𝑇 𝑆𝑢𝑚𝑚𝑎𝑡𝑖𝑜𝑛 = (
1
?̇?1+?̇?2+⋯
) ((?̇?1𝐴𝐵𝑇1) + (?̇?2𝐴𝐵𝑇2) + ⋯)   (7.1) 
where ?̇?1 and ?̇?2 are the flowrates of branches 1 and 2, respectively, and 𝐴𝐵𝑇1 and 𝐴𝐵𝑇2 
are the average bulk temperatures of branches 1 and 2, respectively.   
 An image of the temperature distribution for the 35mm planes from HH88 LAD (Fig. 




        
 
Figure 7.18. HH88 LAD bifurcations of 35mm branches A, B, and C (a). The majority of 
chilled infusate flowed into branch A and only a minute amount passed into branches B 
and C. The cross-sectional 35mm ABT planes (b) are summed together in STAR-CCM+ 




The ABT’s for branches A, B, and C from HH88 LAD were plotted (Fig. 7.19) to 
visualize the flow in each bifurcation between the 10mm and 65mm planes (see 
Appendix D for a qualitative analysis of how ABT contours change along the fluid flow 




35mm ABT Planes 








Figure 7.19. HH88 LAD with 29.2 ml/min proximal infusate flow comparing the ABT 




STAR-CCM+ post-processing allowed us to calculate the ABT summations (Eq. 
7.1) for each location along the artery pathway by creating an average bulk temperature 
report. The results of each stratified ABT were plotted as a function of distance along the 






Figure 7.20. GuideLiner® flow rate (29.2 mL/min) in HH88 LAD with no impact of flow 
stratification using ABT summation from branches A, B, and C. The ABT’s for each 
corresponding distance were summed together to determine a final ABT at each distance 
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The flow stratification from HH97 was resolved using the same method from 
HH88. Cross-sectional planes were created in 5mm increments that extended down the 





Figure 7.21. Continuation of planes in 5mm increments along each bifurcated branch that 




The CFD simulation was executed for Fig. 7.16 and the ABT’s from the 
GuideLiner® inlet to the cross-sectional plane at 35mm were plotted comparing the ABT 










Figure 7.22. HH97 ABT’s comparing the vessel pathway of interest vs the combined ABT 




Having closely examined the impact of vascular geometry on cooling, at a single 
flow rate, the next logical exploration involved alternative cooling catheter operating 
conditions.  The 7F guiding catheter and 7F GuideLiner® used in the in vitro mock loop 
system (see chapter 4) was implemented for the purpose of determining how the guide 
catheter and GuideLiner® performed in physiological conditions. Guide catheters are 
manufactured in many different lengths and diameters and have many different functions 
in cardiovascular procedures [151]. They can be used as conduits for wire transport, 
contrast injections, and advancing interventional devices. Guide catheters are also known 
for their high kink resistance, device compatibility, and radiopacity features [151]. A 
standard Cordis® 7F guide catheter and GuideLiner® was selected for this study and 
tested in the in vitro mock loop to determine outlet temperatures and corresponding 
flowrates to be used in computational fluid dynamics (CFD) simulations. A visual 






























Figure 7.23. Temperature distributions executed in STAR-CCM+ for all patient-specific 




HH55 LAD HH88 LAD HH97 LAD 





Figure 7.24. Temperature distributions executed in STAR-CCM+ for all patient-specific 




Impact of TH device location placement on cooling effectiveness. Localized 
TH transcatheter procedures in patient-specific heart vasculature can have varying results 
on cooling effectiveness (Figs 7.23 and 7.24). In this section, we analyzed the impact of 
GuideLiner® cooling effectiveness in each patient-specific LAD and LCX vasculature. 
The tip of the GuideLiner® was positioned in the proximal LAD and LCX for each 
human heart, and the ABT distributions for HH55 (Fig. 7.25) and HH178 (Fig. 7.26) 
were compared using flowrates at 29.2 ml/min and 68.85 ml/min for each patient. 
 
HH55 LCX HH88 LCX HH97 LCX 




Figure 7.25. Impact of proximal GuideLiner® placement in the LAD and LCX for HH55 
using 29.2 ml/min and 68.85 ml/min flowrates. ABT’s below black-dotted line represent 





Figure 7.26. Impact of proximal GuideLiner® placement in the LAD and LCX for 
HH178 using 29.2 ml/min and 68.85 ml/min flowrates. ABT’s below black-dotted line 

















HH55 LAD & LCX
HH55 LAD 29.2 HH55 LCX 29.2 Therapeutic Hypothermia































































































































































HH178 LAD & LCX
HH178 LAD 29.2 HH178 LCX 29.2 Therapeutic Hypothermia
HH178 LAD 68.85 HH178 LCX 68.85
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Although identical GuideLiner® flowrates and inlet temperatures were delivered 
to the proximal end of each LAD and LCX HH model, the assumption that each artery 
network will experience identical cooling effectiveness was not found. Effective TH 
temperatures were evident in all LAD and LCX networks, however, the distance by 





Summary of TH cooling effectiveness for all HH patients using 29.2 ml/min and 68.85 
ml/min GuideLiner® flowrates. 
 Effective TH-ABT  
at 29.2 ml/min 
Effective TH-ABT  
at 68.85 ml/min 
Human Heart LAD LCX LAD LCX 
HH55 50mm 35mm 90mm 90mm 
HH88 95mm 60mm > 130mm 95mm 
HH97 55mm 55mm 100mm > 90mm 
HH102 35mm 50mm > 80mm > 90mm 
HH178 45mm 50mm 100mm 95mm 
HH259 35mm 35mm 90mm 105mm 
Note. Therapeutic hypothermia average bulk temperature (TH-ABT) represents the 
distance from the inlet up to and including the plane listed where TH temperature 
conditions exist (<35℃) [152]. The greater-than sign obverse to the distance planes 
signifies that the planes reached the artery outlet, and that effective TH-ABT’s continued 




Based on compact heat exchanger design, surface area to fluid volume ratio is a 
logical parameter to examine for intravascular cooling. Surface area to volume (SA:V) 
ratios were calculated in Chapter 5 (Fig. 5.6) for all LAD and LCX RH models. The goal 
of calculating SA:V ratios was to correlate their impact on heart cooling effectiveness 
levels. The SA:V ratios were grouped in ascending order and plotted vs effective TH-
ABT distance for each corresponding flow rate in the LAD (Fig. 7.27) and LCX (Fig. 




Figure 7.27. Impact of surface area to volume (SA:V) ratios on cooling effectiveness in 
the LAD pathway of interest for each representative heart (RH) model. Cooling 
effectiveness is the ratio of the length of TH-ABT in the mother vessel over the entire 
length of the mother vessel. Therapeutic hypothermia average bulk temperature (TH-
ABT) represents the distance from the inlet up to and including the plane listed where TH 
temperature conditions exist (<35℃). In general, smaller SA:V ratios lead to deeper 
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Figure 7.28. Impact of surface area to volume (SA:V) ratios on cooling effectiveness in 
the LCX pathway of interest for each representative heart (RH) model. Cooling 
effectiveness is the ratio of the length of TH-ABT in the mother vessel over the entire 
length of the mother vessel. Therapeutic hypothermia average bulk temperature (TH-
ABT) represents the distance from the inlet up to and including the plane listed where TH 
temperature conditions exist (<35℃). In general, smaller SA:V ratios lead to deeper 





Figures 7.27 and 7.28 reveal the impact of SA:V ratios, listed from left to right in 
ascending order, on cooling effectiveness in the fluid pathway of interest for all LAD and 
LCX artery models. Three GuideLiner® flowrates at 29.2 ml/min, 49.03 ml/min, and 
68.85 ml/min were infused eccentrically at each proximal inlet and compared to the max 
distance in the pathway of interest where ABT’s contained TH (<35℃) temperatures. 
LAD artery simulations for RHs HH55, HH88, HH97, and HH102 revealed a 
direct correlation between effective TH cooling and low SA:V ratio values for all three 














































LCX Flowrates vs Effective TH-ABT (<35℃)
68.85 ml/min 49.03 ml/min 29.2 ml/min SA:V Ratio
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revealed a direct correlation between effective TH cooling and low SA:V ratio values at 
49.03 ml/min and 68.85 ml/min flowrates. 
As mentioned in Chapter 5, SA:V ratios are small in artery networks with 
enlarged internal volumes [142]. This implies that TH cooling will be conserved 
downstream since blood flow temperatures drastically differ from surrounding tissue 
when moderately large vessels experience blood flow [149]. Small SA:V ratios reveal 
that for every unit of volume, there is less surface area to exchange heat. If a vascular 
network maintains larger diameters directly near or near distal to the guide extrusion tip, 
the cooling effect will travel deeper in the vessel. Therefore, small SA:V ratios imply 
larger vessels.  
A sensitivity analysis for proximal LAD and LCX lengths with respect to cooling 
effectiveness was determined for the 68.85 mL/min GuideLiner® flow rates. Figures 7.29 
and 7.30 illustrate the sensitivity of proximal length to the total mother vessel length for 








Figure 7.29. Sensitivity of proximal length to mother vessel length for each HH LAD 
model. Proximal length revealed significant sensitivity to cooling effectiveness in HH88 
and HH102, as the two longest proximal length revealed the greatest cooling 
effectiveness. However, no significant sensitivity was determined between the remaining 





Figure 7.30. Sensitivity of proximal length to mother vessel length for each HH LCX 
model. Proximal length revealed no significant sensitivity to cooling effectiveness since 
the longest (HH178) and shortest (HH55) proximal artery lengths played very little 

























































Sensitivity of LAD Proximal Length to Mother Vessel Length
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Cooling effectiveness in each mother vessel was illustrated for the LAD (Fig. 
7.29) and LCX (Fig. 7.30). Proximal artery lengths ranged between 12mm to 31.7mm in 
the LAD and 9.23mm to 57.5mm in the LCX. The sensitivity of the proximal artery 
lengths to the total mother vessel lengths provided no significant correlation to cooling 
effectiveness for all HH models.  
To increase the rigor of our analyses, the entire vascular networks were 
characterized to determine the impact of cooling effectiveness down each first and second 
obtuse marginal branch and posterolateral branch in the LCX, and down each first and 
second diagonal branch, septal branch, and anterior descending branch in the LAD. Total 
cooling in the vascular network was determined using cooling effectiveness from each 








        (7.1) 
where 𝜂𝑇𝐶  is total cooling in the vascular network (𝜂𝑇𝐶  = 1 represents 100% CE), 𝐿𝑒 is 
the effective length in each branch of interest where TH-ABTs < 35°C, L is the total 
length of each branch of interest, and 𝑁 represents the sum of the total number of 
branches in the network of interest.  
 A visual representation of Eq. 7.1 applied to the LCX artery of patient’s HH88, 







Figure 7.31. Characterization of vascular networks for HH88, HH97, and HH259 LCX 
represented using 68.85 mL/min GuideLiner® flow rates. First obtuse marginal (1om), 
second obtuse marginal (2ob), and posterolateral (Plb) branches were characterized using 
Eq. 7.1. Total cooling 𝜂𝑇𝐶  in HH97 resulted in 97.63% CE in the artery network, while 





We acknowledge this method is subjective, and intend that it be used as a simple 
aid to help and support patient care. The purpose of the proposed method is to help 
stimulate a deeper understanding of intracoronary cooling and provide a deeper 
understanding of TH treatment methods to improve patient outcomes following AMI. 
The HH97 LCX artery network resulted in having 97.63% CE in its total vascular 
network, and would be recommended as a good candidate for localized cooling therapy. 
On the other hand, we would be reluctant to recommend HH88 and HH259 LCX arteries 
as candidates for this treatment due to their moderate total network cooling potential of 
85.26% and 76.02%, respectively. 
 The total network cooling effectiveness for patients HH55 and HH178 was not 
included in the following analyses due to poor mother vessel and total network cooling 
HH259 LCX  
𝜂𝑇𝐶 = 76.02% 
HH97 LCX  
𝜂𝑇𝐶 = 97.63% 
HH88 LCX  
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performance. The remaining patient models provided good cooling performances and 
were analyzed using a dimensionless parameter of SA:V multiplied by total network 
length. These values were plotted against 𝜂𝑇𝐶  and mother vessel cooling effectiveness for 






Figure 7.32. Analyses of total network cooling effectiveness (𝜂𝑇𝐶) for each HH model 
compared to SA:V ⋅ total network length. Triangle markers represent mother vessel 
cooling effectiveness (𝐿𝑒/𝐿) for each HH model at 68.85 mL/min GuideLiner® flow rate, 
while circles represent SA:V ⋅ total network length for each HH model. A significant 
reduction in total network cooling effectiveness is evident when SA:V ⋅ total network 
length ratios exceed 700. Note: red dotted line represents 700 cut-off value between good 




Total network cooling effectiveness is significantly reduced when SA:V ⋅ total 































































Impact of SA:V ⋅ Total Network Length to 𝜂𝑇𝐶
SA:V ⋅ Total Network Length Mother Branch Cooling Effectiveness
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is reduced from 97.63% to 85.26%. This is also indicative of the fact that mother vessel 
cooling effectiveness also followed suit by decreasing from 100% to 74.8%. The 
comparison between these two trends suggest that a cutoff of 700 SA:V ⋅ total network 
length ratio could be approximated as a reasonable localized cooling candidate parameter. 
However, this assumption is limited by the number of patient-specific vascular models 
employed in this study. A more robust analysis is needed to increase the fidelity of this 
assumption by improving upon the modeling physics of the CFD simulations and 
broadening the patient-specific model population.  
In lieu of the importance of these findings and insights attained from this study, a 
comparison of HH specifications and published works must also be made to preserve the 
fidelity of this work. 
Comparison with Published Works 
Patient-specific heart specifications, medical history, and intracoronary 
temperature predictions were compared with published works that performed similar 






















Comparison of patient specifications and medical history with patients in similar heart 
cooling studies. 
Comparison of Work Present Work Otterspoor [13] McGarvey [96] 
Intracoronary Temperature 
Goal 
<35℃ at each 
artery outlet 
5℃ below body 
temp. proximal 
to occlusion 
3.4℃ below body 
temp. proximal to 
occlusion 
Patient population N = 6 N = 10 N = 10 
Cooling Location 
LAD (N = 6) 
LCX (N = 6) 
LAD (N = 6) 
LCX (N = 1) 
RCA (N = 3) 
LAD (N = 3) 
Mid-LAD (N = 2) 
LCX (N = 1) 
RCA (N = 4) 
Sex 
Male N = 3 N = 7 N = 9 
Female 
N = 2 
(1 unknown) 
N = 3 N = 1 
Age 
41 ± 27 
(1 unknown) 
61 ± 11 55 ± 8 
Medical History  
Diabetes Mellitus N = 1 N = 3 N = 2 
Smoking N = 1 N = 5 N = 6 
Cardiac Medical History  
Cardiac Arrest N = 1 --- --- 
Hypertension N = 2 N = 5 N = 2 
Sinus Bradycardia N = 2 --- --- 
Note. Left anterior descending artery (LAD), left circumflex (LCX), and right coronary 




Hypothermia trials have found that patients who undergo therapeutic hypothermia 
treatments with temperatures <35℃ prior to reperfusion result in reduced infarct sizes 
[152]. Figures 7.33 to 7.39 illustrate the structural-thermal relationship of preferred 














Figure 7.33. Structural-thermal relationship in HH88 LAD for 49.03 ml/min guide 
extension flow rate. Note proximal guide extension inlet temperature is 23.16℃, and 











Figure 7.34. Structural-thermal relationship in HH88 LAD for 68.85 ml/min guide 
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LAD 






Figure 7.35. Structural-thermal relationship in HH97 LCX for 68.85 ml/min guide 
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LCX 








Figure 7.36. Structural-thermal relationship in HH102 LAD for 49.03 ml/min guide 
extension flow rate. Note proximal guide extension inlet temperature is 23.16℃, and 









Figure 7.37. Structural-thermal relationship in HH102 LAD for 68.85 ml/min guide 
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LAD 

















Figure 7.38. Structural-thermal relationship in HH102 LCX for 49.03 ml/min guide 
extension flow rate. Note: proximal guide extension inlet temperature is 23.16℃, and 







Figure 7.39. Structural-thermal relationship in HH102 LCX for 68.85 ml/min guide 
extension flow rate. Note: proximal guide extension inlet temperature is 19.2℃, and LCX 




Intracoronary TH cooling techniques employed in our study resulted in 
predictions that were similar to the results of the following published works. 
In a study performed by Otterspoor et al., chilled saline was delivered proximal to 
occluded arteries in the LAD using 10-30 mL/min flow rates at 20℃ [13]. The goal of the 
study was to reach a target temperature of 33℃ in the distal LAD using a 10 patient 
population. Temperature probes monitored the temperature of the saline during each 





Figure 7.40. Temperature vs time plot for the proximal, mid, and distal infarct 
temperature probes during the infusion of chilled saline at 20℃ in the coronary arteries. 
Proximal intracoronary temperatures reached 30℃ during the occlusion phase and 
increased to ~33℃ for the duration of reperfusion prior to reaching body temperature at 




 A preceding study also analyzed a ten patient population but targeted their therapy 
towards patients with percutaneous coronary interventions (PCI) only, rather than those 
suffering from ST elevated myocardial infarction (STEMI). This study involved the use 
of TH during PCI with the goal of reducing intracoronary blood temperatures by 3.4℃ 





Figure 7.41. Temperature vs time display for intracoronary blood temperatures using TH 
therapy during PCI. Intracoronary blood temperatures were targeted consistently 
maintained around 33℃ for the duration of the procedure. TH temperatures were 





Each of the ten patients were infused with chilled saline proximal to an occlusion 
until their intracoronary blood temperatures reached 33℃. Target temperatures of 33℃ 
was consistently maintained for the duration of the procedure.  
As observed in Fig. 7.40 and Fig. 7.41, intracoronary blood temperatures were 
reduced to 33℃ locally in both the LAD and LCX arteries. Although these studies 
comprise of small patient populations, each study reported positive outcomes following 
the procedure with no signs of patient discomfort from shivering while reaching and 
maintaining target TH temperatures in minutes [13][97]. While these therapies observed 
the duration to reach and maintain target TH temperatures in the LAD and LCX arteries, 
the impact of reducing infarct and the relation between distal artery temperature with 
myocardial temperatures have yet to be explored.  
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Despite the fact that localized TH targeted temperature management (TTM) is a 
relatively new therapy, Abbott Laboratories, a world renown biotechnology company, 
has recently initiated a randomized interventional clinical trial in Europe involving 200 
patients with an estimated study duration of three years (January 1, 2019 to January 1, 
2022) [146]. The goal of this study is to combine selective intracoronary hypothermia 
with primary percutaneous coronary interventions (PPCI) to reduce infarct size and 
permanent myocardial damage. 
Similarly, our aim was to determine the impact of patient-specific coronary artery 
vascular structures on localized therapeutic hypothermia cooling. We chose six patient-
specific LMCA representative heart (RH) models from the VHL and compared 
temperature distributions for a variety of flowrates in the LAD and LCX arteries. The 
structural thermal-fluid relationship was compared between each LAD and LCX 
simulation to determine cooling effectiveness levels. Based on their cooling 
effectiveness, we categorized each RH model as a preferred candidate or non-preferred 
candidate for localized heart cooling. The key takeaways and insights revealed from this 






Conclusions and Future Work 
Approaches and Recommendations for Cooling Hearts 
 
Patient-specific left anterior descending (LAD) and left circumflex (LCX) artery 
structures and their impact on cooling effectiveness have been quantified using the finite 
volume method.  Surface area to volume ratios, relationships between mother and 
daughter branches, and effective depth of therapeutic hypothermia have been explored.  
Preferred candidates for localized cooling consisted of heart structures that 
resulted in TH-ABT at the outlets. As illustrated in Fig. 7.32 from Chapter 7, a significant 
reduction in total network cooling effectiveness is evident when SA:V ⋅ total network 
length ratios exceed 700. Any value below this ratio resulted in total network cooling 
effectiveness levels greater than 97.63 %, while values above this ratio resulted in total 
network cooling effectiveness levels below 85.26%. Therefore, preferred candidates had 
structural-thermal relationships linked to low values of SA:V ratios multiplied by total 
network length (Chapter 7 – Fig. 7.32).  
High GuideLiner® infusate flow rates, specifically greater than and including 
49.03 mL/min, were linked to TH-ABTs deep within the LAD and LCX mother vessels. 
Average cooling potential depth was slightly higher in the LAD mother vessel compared 







Figure 8.1. Average cooling potential depth in the LAD and LCX mother vessel. LAD 
average cooling potential was deeper in each mother vessel compared to the LCX. 




The standard deviation for each average TH-ABT depth potential was smaller 
with higher flow rates, and resulted in smaller deviations in the LCX arteries. Preferred 
heart cooling candidates were linked to GuideLiner® flow rates above 49.03 mL/min, 
which not only provided deeper cooling potential, but also provided a tighter standard 
deviation which improved accuracy for maintaining TH-ABTs. 
A linear regression model was used to determine the relationship between input 
and output parameters from our CFD results. For this study, we analyzed the relationship 
between mother vessel CE (input) and 𝜂𝑇𝐶  (output). These parameters were investigated 
for each GuideLiner® flow rate (Fig. 8.2) and a best fit linear regression model was used 




































Average TH-ABT Distance for each GuideLiner® Flow Rate 








 The linear regression model for each GuideLiner® flow rate resulted in the 
highest flow showing the most promise for providing an accurate model. High 
GuideLiner® flow rates (68.85 mL/min) resulted in an 𝑅2 value of 0.9273, which 
statistically associated the percent variance between the dependent variable (𝜂𝑇𝐶  for each 
HH model) and the independent variable (mother vessel CE). Medium GuideLiner® flow 
rates (48.03 mL/min) resulted in having an 𝑅2 value of 0.8843, while the low flow rate 
(29.2 mL/min) resulting in an 𝑅2 value of 0.589, which is a statistically poor model. 
Therefore, the above linear regression models have demonstrated that GuideLiner® flow 
rates have a significant impact on 𝜂𝑇𝐶  predictions. 
Heart candidates that had fewer bifurcations stemming from the mother branch 
and fewer number of outlets in the artery network generally resulted in having better 
cooling outcomes, meaning TH-ABTs were able to travel deeper into the mother vessel. 
These results are illustrated by a linear fit trendline to the scatter plot data representing 
the number of diverting branches from the mother vessel (Fig. 8.3) and the number of 





Figure 8.3. The relationship between the number of diverting branches from the mother 
vessel and decreasing total network cooling effectiveness (𝜂𝑇𝐶) (from left to right). The 
linear fit trendline suggests that 𝜂𝑇𝐶  is likely to decrease as the number of diverting 





Figure 8.4. The relationship between the number of outlets in the LAD and LCX artery 
network and decreasing total network cooling effectiveness (𝜂𝑇𝐶) (from left to right). The 

































































Diverting Branches from Mother Vessel vs Decreasing 𝜂𝑇𝐶























































Number of Outlets in Network vs Decreasing 𝜂𝑇𝐶
Number of Outlets in Artery Network Linear (Number of Outlets in Artery Network)
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Heart candidates that had an increasing amount of outlets in the LAD and LCX 
artery network tended to have poorer 𝜂𝑇𝐶 . The linear trendline model was used to 
determine a relationship between the number of diverging branches from the mother 
vessel and the number of outlets in the artery network for each candidate’s 𝜂𝑇𝐶 . We 
recommend that the linear model only be considered as an optional parameter for 
determining optimal TH outcomes for each patient. Since a larger patient-specific 
population in needed to confirm the fidelity of this assumption, all LAD and LCX artery 
networks expressing these “features” are not necessarily indicative of preferred 
candidates for heart cooling.  
To determine which methods promote effective cooling in the LAD and LCX 
arteries, the TH-ABT depth potential was analyzed. This method involved analyzing the 
ratio of TH-ABT depth with respect to the length of the mother vessel and comparing 
those values to their corresponding flow rates in ascending order of SA:V ratios. A 
narrative of good and bad candidates for localized cooling in the LAD (Fig. 8.5) and 







Figure 8.5. Percent of LAD pathway (mother vessel) experiencing TH-ABT. Increasing 
SA:V ratios are from left to right for each flow rate. HH88 and HH102 resulted in 100% 
effective rates at 49.03 and 68.85 ml/min flow rates. Effective rates of 100% result in 




































Figure 8.6. Percent of LCX pathway experiencing TH-ABT. Increasing SA:V ratios are 
from left to right for each flow rate. HH102 and HH97 resulted in 100% effective rates at 
49.03 and 68.85 ml/min flow rates in HH102 and 68.85 ml/min in HH97. Effective rates 




Preferred candidates for LAD and LCX heart cooling are represented by the bars 
that reached 100% TH-ABT effective levels in Figures 8.5 and 8.6. This means that each 
bar reaching 100% effective levels had ABT’s less than 35℃ exiting the LAD and LCX 
mother branch outlets. Cooling effectiveness is determined by dividing the length of the 
LAD that reached ABTs <35°C divided by the total length of the LAD. For some 
patients, increasing the flow rate seemed to have little effect on adding cooling 
effectiveness in each LAD mother vessel. For the remaining patients, we can assume that 
49.03 ml/min GuideLiner® flow rate is sufficient to use in TH intracoronary procedures 



























HH55 HH102 HH259 HH88 HH178 HH97
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order (Fig. 8.5), which resulted in no identifiable trends that link cooling effectiveness to 
increased values of SA:V for the entire LAD network. 
A slight trend between high SA:V ratios in most of the patient-specific LCX 
models is apparent compared to low SA:V ratios (Fig. 8.6). Cooling effectiveness in the 
LCX appeared to trend differently than the LAD data where increased SA:V ratios in the 
LCX tended to lead towards greater cooling effectiveness. Contrarily, the LAD resulted 
in no identifiable trends between SA:V ratios and cooling effectiveness. GuideLiner® 
flow rates above and including 49.03 ml/min were 33.3% effective at delivering TH-ABT 
at the distal LAD outlets, and 25% effective at the LCX outlets. 
The remaining 66.7% of LAD candidates that experienced proximal flow rates 
greater than 49.03 ml/min were considered bad candidates for heart cooling since their 
TH-ABT’s only traveled ≤ 60% into the mother branches, with the exception of one that 
travelled 73.08% into the mother branch (Fig. 8.5). Additionally, 75% of LCX candidates 
that experienced proximal flow rates greater than 49.03 ml/min were considered bad 
candidates for heart cooling since their TH-ABT’s only traveled ≤ 74.8% into the mother 
branches, with the exception of one that travelled 88.9% into the mother branch (Fig. 
8.6).  
Decreasing values of 𝜂𝑇𝐶  were compared to the ABT at each LAD and LCX 
artery mother vessel outlet. ABT data for all three GuideLiner® flow rates were plotted 
vs decreasing 𝜂𝑇𝐶  and the seven preferred heart cooling candidates were isolated using a 







Figure 8.7. Mother vessel outlet ABT data plots for each GuideLiner® flow rate vs 
decreasing 𝜂𝑇𝐶  values. Seven recommended heart cooling candidates are isolated in the 





TH-ABTs were evident in the remaining seven out of the total thirty-six CFD 
simulations at the distal LAD and LCX posterolateral outlets for 49.03 ml/min and 68.85 






GuideLiner® flow rates associated with TH-ABT’s leaving the LAD and LCX outlets. 









HH88 LAD 130 34.13 130 32.69 
HH97 LCX --- --- 90 34.55 
HH102 LAD 80 33.1 80 30.47 
























































ABT at Mother Vessel Outlet for each GuideLiner® Flow Rate
68.85 mL/min 49.03 mL/min 29.2 mL/min
150 
 
 TH-ABT in the LAD and LCX mother vessels varied in temperature at the outlet 
for each HH model and GuideLiner® flow rate. As shown previously, higher flow rates 
tended to yield cooler ABTs along the artery pathway. However, Table 8.1 shows that not 
all patients experiencing 68.85 mL/min GuideLiner® flow rates revealed lower ABTs 
compared to 49.02 mL/min GuideLiner® low rates. While each patient-specific coronary 
artery network is unique to the number of branches, outlets, and artery dimensions it has, 
the critical factor to consider is that ABTs vary in each patient’s LAD and LCX artery 
regardless of GuideLiner® flow rate. 
Summary. In summary, three distinguishable methods were obtained from this 






Good and bad heart cooling candidates as recommended assuming 68.85 mL/min 
proximal GuideLiner® flow rate. 
Insight 
Number 
Good/Bad Candidate Evaluation for Recommended 𝛈𝐓𝐂 
1 Number of diverting branches from 
mother vessel (Fig. 8.3) 
Recommended 
cut-off value 
Avg. / ST Dev. 
 Good Candidate ≤ 6 4.5 +/- 1.9 
 Bad Candidate ≥ 7 6.5 +/- 3.5 
2 Number of outlets in artery 
network (Fig. 8.4) 
  
 Good Candidate ≤ 11 6.4 +/- 2.0 
 Bad Candidate ≥ 12 13.1 +/- 7.4 
3 SA:V · Total Network Length  
(Fig. 7.25) 
  
 Good Candidate ≤ 700 539.2 +/- 108.8 
 Bad Candidate ≥ 701 893 +/- 210 
Note. Recommended cut-off value for good candidates represents the max value where 
𝜂𝑇𝐶 ≥ 97.63%. The cut-off value for bad candidates represents the lowest value where 
𝜂𝑇𝐶  ≤ 85.26%. Values 1 and 2 are estimated values determined using linear regression 




While these insights help to provide recommended guidelines for determining 
preferred candidates for heart cooling, a few exceptions were identified in bad candidate 
hearts where good candidate characteristics were evident. Patient HH259 is a good 
example of a bad heart cooling candidate even though it contained LAD and LCX 
branches stemming from the mother vessel that fell within preferred candidate ranges 






Good and bad heart cooling candidates with their corresponding number of outlets and 
vessel branches stemming from the mother branch. 








HH55 7 13 14 30 
HH88 2 3 7 8 
HH97 8 6 10 7 
HH102 6 4 11 7 
HH178 9 5 14 11 
HH259 5 2 12 6 
Note. Mother vessel = 𝑀𝑣 and total network = 𝑇𝑛. Preferred heart cooling candidates are 




A combination of the three methods described in Table 8.2 for determining which 
candidates are suitable for localized intracoronary heart cooling involved determining the 
number of branches stemming from the mother branch of interest, the number of outlets 
in the LAD and LCX artery networks, and the surface area to volume ratio multiplied by 
the total network length for each patient-specific LAD and LCX artery. Implementing 
these three methods, as well as employing the appropriate proximal GuideLiner® flow 
rates prior to a localized intracoronary heart cooling procedure will help to provide 
insight on the potential outcome of cooling effectiveness. The computational work 
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described herein provides a foundation to guide cardiovascular interventionist’s use of 
therapeutic hypothermia to optimize cooling performance and patient outcomes. 
Future work 
Geometry. Future work for this study should be focused on attaining additional 
heart models from the Visible Heart Lab (VHL) website and additional resources where 
higher DICOM image resolutions are available. Since the vasculature is not rigid, future 
work should also explore fluid-structure interaction.  
Additional heart models. Implementing additional heart models will introduce 
more anatomical variations which could help improve the accuracy of our predicted 𝜂𝑇𝐶  
to SA:V ⋅ total network length ratios in each mother vessel. Executing a large range of 
patient-specific heart models will broaden the scope of this work and will introduce an 
extensive collection of patient-specific vascular networks for determining their impact on 
localized TH cooling.  
Physics. The physics solvers employed in the STAR-CCM+ simulations were 
constrained to steady state laminar flow conditions.  Each of the mass flow inlet 
conditions were performed using constant flow rates that exhibited no pulsatile affects. 
Future studies should utilize a pulsatile field function in STAR-CCM+ for both the blood 
and GuideLiner® inlet conditions. This would produce temperature distributions that 
would accurately resemble pulsatile blood flow conditions in the coronary arteries. 
 Non-mixed blood properties should be used at the start of each simulation and 
normal saline at 0.9% NaCl should be used for the GuideLiner® flow instead of distilled 
water. Blood flow behavior would also be improved if unsteady state conditions are 
applied to each model so that time dependent hemodynamic conditions and hematocrit 
levels are considered [4][75][106][123]. 
153 
 
Extending arterial blood temperature predictions towards tissue predictions. 
Vessel wall thickness in future studies should be considered and replicated to extend 
arterial blood temperature predictions towards tissue predictions. Each of the patient-
specific LAD and LCX models had fixed boundary conditions assuming a rigid no-slip 
wall boundary, which should be improved to include wall thicknesses to ultimately 
provide a more accurate representation of the temperature distributions in each artery 
network.   
Validation. Since CFD modeling provides an alternative to experimental 
development, CFD simulations must always be scrutinized and compared with 
experimental results and published data to validate each model’s credibility [134]. 
In vivo validation of cooling effectiveness and myocardial salvage. To validate 
our patient-specific representative heart (RH) models, future efforts should focus on 
patient-specific 3D printed replicas that can be used in in vitro mock loop systems to 
validate the predicted CFD average bulk temperatures.  
Furthermore, in vivo validations could help validate our cooling effectiveness 
levels and methods used to determine good candidates for localized TH cooling. 
Localized TH cooling studies performed in swine are also excellent models that should 
be used to explore additional cooling methods and outcomes [13]. 
The methods described in this thesis work are used to identify ideal candidates for 
localized heart cooling and can be improved and applied in clinical settings where 
patients suffering from SA and STEMI could be recommended as ideal candidates for 
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Simplified explanation of fully developed velocity profile, energy balance, and the 
temperature dependent heat source equation 
 
Velocity Profile Equation 
For incompressible, fully developed laminar flow in a horizontal circular pipe, the 
fluid properties will be assumed constant, and flow will move at a constant velocity along 
the axial length of the pipe. Thus, velocity u(r) is represented as a steady parabolic profile 





Figure A.1. The velocity profile for fully developed laminar flow in a pipe with radius R 
and length L. At R = 0 at the centerline, the velocity is maximum, 𝑣𝑚𝑎𝑥. The velocity 





The radial direction has no fluid motion; thus, the velocity is zero everywhere 
normal to the direction of flow. Since flow is only varying in the r-direction, flow in the 
𝜃 and z direction is neglected, and velocity 
𝜕?⃑? 
𝜕𝑡 
 is ignored due to steady state flow. 
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, is considered a constant. Integrating equation A.1 with respect to the radius 
yields the velocity profile as a function of the pipe radius, where vz is the fluid velocity in 
the z-direction. To solve for a finite vz at the center of the pipe (r = 0), the velocity must 




is zero and vz is maximum.   








) (𝑟2 − 𝑅2)         (A.2) 
where 𝜇 is the viscosity, R is the radius of the pipe, and the velocity distribution in the 




, and volumetric flow rate, Q, by integrating over a finite differential 
area, dA = (2πr)dr, in the pipe. The resulting flowrate, Q, through the pipe becomes the 




             (A.3) 
where the volumetric flow rate, Q, is proportional to the radius, R, to the fourth power 
and inversely proportional to viscosity, 𝜇. 
Energy Balance - Governing Equations 
The following derivation is a mathematical model used to predict the temperature 
profile of a non-isothermal laminar fluid through a simple pipe with constant wall 
temperatures. The derived equation will predict flow through a tubular pipe with constant 
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heated walls to determine the pipes outlet temperatures. The energy balance for a horizontal 
pipe system with heat and work [154] can be described as,  
𝑞 − 𝑤 + ∑𝐸𝑖𝑛 − ∑𝐸𝑜𝑢𝑡 =
𝑑
𝑑𝑡
(𝐸𝑠𝑦𝑠)         (A.4) 
where q is the convective heat flux from the surface of the pipe into the fluid, w is work, 
and 𝐸𝑠𝑦𝑠 is the total energy change in the computational domain of the pipe with respect to 
time.  
 To apply (A.4) to an energy balance for steady-state, laminar fluid flow in a simple 
horizontal pipe system with constant wall temperatures, there is no work being done, so w 
= 0, and the energy balance becomes an unsteady-state partial differential equation (PDE) 






+ ℎ(𝑇𝑤 − 𝑇𝑖𝑛)
2
𝑅
       (A.5) 
where 𝐶𝑝 is the specific heat, 𝑇𝐴𝐵𝑇 represents the difference in average bulk temperature 
(ABT) of the fluid across the length of the pipe, ?̇? is the mass flow rate, 𝐴𝑐 is the cross-
sectional area of the pipe, ℎ is the heat transfer coefficient, 𝑇𝑤 is the temperature of the 




 in equation (A.5) goes to zero, and if we combine like 
terms, integrate with respect to temperature from 𝑇𝑖𝑛 to  𝑇𝑂𝑢𝑡 across the length of the pipe, 
and rearrange to solve for 𝑇𝑂𝑢𝑡, the final analytical equation for the steady-state 
temperature profile becomes: 
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Temperature dependent heat source equation 
  A common model used to determine the temperature difference between the surface 
of a pipe and its internal fluid flow is the temperature dependent heat source equation [156]: 
𝑄𝑐 = ?̇?𝑐𝐶𝑝,𝑐∆𝑇𝑐      (A.7) 
where 𝑄𝑐 is the cooling capacity and is dependent on the mass flow rate, ?̇?𝑐, the specific 
heat, 𝐶𝑝,𝑐, and the difference between the pipe surface temperature and the outlet 
temperature, ∆𝑇𝑐. 
 In Eq. (A.7), the heat flux, 𝑄𝑐, can also be described as the heat conduction rate, ?̇?, per 





     (A.8) 
where −𝑘 is the thermal conductivity representing the heat-flux moving from high to low 
temperatures, Δ𝑇𝑤 is the change in temperature between the outer and inner wall, and Δ𝑥 

















Description of viscosity entered as function of temperature in STAR-CCM+ 
 
As discussed in Chapter 2, Equation 2.11, was used to determine the dynamic 
viscosity as a function of mixed temperature 𝑇𝑚 (℃), shear rate Υ (
1
𝑠
), and hematocrit 
(Hct (%)) for each GuideLiner® flow rate [123].  





]     (2.11) 
Equation 2.11 was used to solve for dynamic viscosity in each of the thirty-six 
CFD simulations. The ABT at each discrete location along the fluid flow path was plotted 





Figure B.1. ABT along the fluid flow path for HH63 LAD vs dynamic viscosity using 
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A Polynomial in T function was used to replicate the slope of Fig. B.1 to 
represent the independent variables (shear rate, hematocrit, and temperature) and the 
dependent variable (dynamic viscosity) from Eq. 2.11 and were entered as a function of 









The slope from Figure 2b is an extrapolation of Figure 2a which was entered as a 
function in STAR-CCM+ and applied to all thirty-six patient-specific CFD simulations. 
A constant viscosity at 32.5°C was for the 28.5 mL/min GuideLiner® flow rate 
was plotted with a polynomial in T function against temperature along the fluid flow path 






Figure B.3. ABT at discrete locations along HH63 LAD fluid flow path at 29.2 mL/min 




The Polynomial in T data fit the constant viscosity assumption fit fairly well with 
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Extension of the thermal fluid modeling matrix specifications 
 
An extension of the thermal fluid model testing matrix is herein described for 
each patient-specific representative heart model. A more comprehensive version of the 
specifications are described in detail in the following tables – courtesy of the Atlas of 
Human Cardiac Anatomy from the Visible Heart Lab, University of Minnesota. 
Figures C.1 – C.4 illustrate an extension of the thermal fluid modeling matrix of 
heart histories and specimen demographics. The information from Figure C.1 is freely 

































Qualitative analysis of how ABT changes along the fluid flow path using simple 3D 
tube flow in STAR-CCM+ 
 
As illustrated in Chapter 7, ABTs increased along the length of the arteries and 
experienced dramatic increases in ABT where vessels branched or artery diameters 
significantly reduced in size. For the simple 3D tube case, however, a slight increase in 





Figure D.1. ABT cross-sectional planes along 3D tube for simple pipe flow using 28.5 




 The sudden increase in slope between the Proximal 8 and Mid 1 cut planes was 
due to a 3x gap extension implemented for the remaining Mid cut planes. The extended 
gap between cut planes and contour ABT plots along the fluid path of the 3D tube are 






















Figure D.2. Contour plots of the ABT cross-sectional planes as illustrated in Fig. 3a at 
each location along the length of the simple 3D tube. Mixing between the chilled saline 
(blue) and blood (red) increases as flow continues down the length of the tube, with the 




 Figure D.2 illustrates the mixing effect between GuideLiner® and blood flow by 
considering the temperature contours at each cross sectional plane within the tube. To 
visualize the flow field and temperature distribution within each artery vessel, each fluid 
is colored with respect to temperature, with chilled distilled water (blue) and blood (red). 
It is evident that mixing and rewarming occurs downstream in the tube since the majority 
of the contour color falls within yellow and green temperatures (25-33°C), which is much 
higher than the temperature at the GuideLiner® inlet (13.33°C). Since this method was 
applied to each RH model, custom cross-sectional planes were created along each fluid 
flow path so that temperature distributions could be investigated for each patient-specific 
vascular network. 
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